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ABSTRACT
Microdialysis (MD) sampling is a diffusion-based separation method which has the
ability to sample any analyte that can diffuse across the semi-permeable membrane. However
one challenge for MD is that for soluble proteins greater than 10 kDa, the relative recovery (RR)
using a 100 kDa MD probe is between 1-5%.1 There are two major barriers that lead to these
low recovery values - nonspecific adsorption (NSA) and poor solute mass transport. To
overcome these two barriers, the modification of PES-based MD membranes has been initiated
by laccase. Previous researchers have used laccase to modify PES flat sheet and hollow fiber
membranes using 4HBA to create a hydrophilic polymer chain network.2 Furthermore by
functionalizing the MD membranes with carboxylic acid functional groups from 4HBA, one can
easily modify the surface.3 This study focuses on characterization of the PES membrane surface
before and after attachment of 4HBA polymers and heparin. First the attachment of 4HBA and
heparin has been confirmed using XPS and ATR-FTIR. Next protein adsorption measurements
were performed for 4HBA modified flat sheets which showed an initial increase in BSA
adsorption followed by a decrease in BSA adsorption after 24 hours of modification. However,
for positively charged lysozyme the protein adsorption increased upon modification. RR
experiments were performed using FITC-labeled dextrans, lysozyme, CCL2, VEGF, TNF-,
KC/GRO and aFGF. After modification with 4HBA for 2 hours, RR of CCL2, KC/GRO, and
VEGF increased 2 to 3 times compared to the control relative recovery however, this increase in
RR was not observed for aFGF and TNF-. This difference could be due to the isoelectric
points (pI) of these proteins indicating an electrostatic interaction between the surface and the
protein. For 24 hour 4HBA-heparin modified membranes CCL2 RR increased twofold for hours
3 and 4 and for 2 hour 4HBA-heparin modified membranes aFGF RR increase threefold.
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Analyte concentration external to the probe

[A]free

Free analyte concentration

[AB]

Concentration of analyte bound to affinity agent

[B]free

Free affinity agent concentration

C10

Concentration of species 1 at distance 0

C1l

Concentration of species 1 at distance l

Cinlet

Concentration of analyte added in the perfusion fluid

Coutlet

Concentration of analyte in the dialysate

Csample

Concentration of the analyte in the sample

Deff

Effective diffusion coefficient

H

Partition coefficient

J

Flux

KD

Equilibrium dissociation constant

koff

Off-rate constant

kon

On-rate constant

l

Length

Mx

Molecular weight

Nx

Number of molecules of Mx size

CHAPTER 1. INTRODUCTION

Significance
The work in this dissertation is focused on developing membranes to improve mass
transport through covalent addition of 4-hydroxybenzoic acid (4HBA) polymers, and heparin to
the microdialysis membrane surface. One significant challenge to microdialysis is that mass
transport is low for large soluble signaling proteins (>10 kDa). These signaling molecules help
cells, perceive and respond to their microenvironment and are found to be involved in processes
such as inflammation, and immunity.4 Another challenge for microdialysis is the nonspecific
adsorption of protein molecules to the dialysis membrane and tubing, this decreases the effective
pore size of the membrane and causes loss of analytes, leading to a decrease in recovery.5 By
attaching hydrophilic phenolic compounds (4-hydroxybenzoic acid polymers) onto the
membrane surface, relative recovery of CCL2, KC/GRO, and VEGF, after 2 hours of
modification increase two to three times and relative recovery of aFGF increased at hour 4. RR
of TNF- did not increase for the 2 hour 4HBA modification. The difference between these two
groups of proteins is their isoelectric point’s which can indicate an interaction between the
charged surface and the overall charge of the protein. By covalent attachment of heparin to the
membrane, relative recovery of CCL2 increased two times after hour 2 and VEGF increased for
the 24 hour 4HBA modified MD probes and aFGF relative recovery, after a 2 hour 4HBA
modification time, increased starting at hour 3.
Microdialysis Sampling
Microdialysis sampling is a diffusion-based separation method that allows analytes to
freely diffuse across a semi-permeable dialysis membrane (Figure 1).3
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Cinlet
Coutlet
Csample
Semi-permeable
membrane

Figure 1. Microdialysis probe and relative recovery experimental design.

Commercially available membranes range in molecular weight cut-off (MWCO) from 6 to 1,000
kDa and are made up of a variety of membrane materials such as polyethersulfone,
polycarbonate, and polyarylethersulphone. Microdialysis sampling of a given analyte is
governed by the mass transport of the molecule from an external medium, through the
membrane, and into the perfusing fluid.6 Factors such as membrane physical dimensions, device
accessible volume, perfusate flow rate, and analyte diffusion coefficients strongly influence
relative recovery.6 Microdialysis sampling is an ideal technique to achieve real time monitoring
at the site of probe implantation within living systems.7 The application of microdialysis is
emerging as an approach for clinical in vivo studies in both healthy and diseased subjects to
recover targeted molecules.8-11 Microdialysis probes are made with a variety of MWCO’s and
membrane chemistry. MWCO is defined as the molecular weight at which 80% of the analyte is
prohibited from membrane diffusion.12 However, MWCO is typically determined from
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equilibrium mass transport, which is not an exact representation of the non-equilibrium setting of
microdialysis.6 One of the parameters commonly measured for microdialysis is relative recovery
(RR). This is used to estimate the concentration external to the probe.
RR 

Co u tlet  Cin let
Csa m p le  Cin let

[1]

As shown in Equation 1, RR is defined by the difference between the concentration of analyte in


the dialysate (Coutlet) and the concentration of analyte added in the perfusion fluid (Cinlet), which
is typically zero, divided by the difference between the concentration of the analyte in the sample
(Csample), and Cinlet multiplied by 100. RR is dependent on many factors such as the perfusion
flow rate, membrane surface area, MWCO, and temperature, analyte, and matrix properties of
the external media.10, 13-15 As the flow rate decreases the concentration of analyte in the dialysate
increases leading to an increase in relative recovery. Also as the surface area of the membrane
increases, relative recovery increases due to the increase of contact between the solution and the
membrane surface. An increase in MWCO leads to increased relative recovery however with
increasing the MWCO, ultrafiltration leading to fluid loss in the dialysate becomes an issue.
There are several techniques used to determine RR for in vivo studies, in vitro microdialysis, nonet flux, ultra-slow or zero flow rate method, internal standard, endogenous reference and
retrodialysis.16 The most commonly used technique is an in vitro recovery experiment, where
the probe is placed in a solution containing a known amount of the analyte. The perfusion fluid
is perfused through the probe and collected for quantification of the analyte. RR can then be
calculated using Equation 1, knowing the external concentration in which the probe is placed and
the amount collected in the perfusion fluid.
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Challenges to Microdialysis Sampling
Microdialysis is a diffusion-based technique, so RR is highly dependent upon analyte
diffusion properties.7 Since microdialysis is not an equilibrium process due to the continuous
flow of the perfusion fluid, RR is generally less than 100%.7 One of the challenges for
microdialysis sampling is that for soluble proteins greater than 10 kDa the RR using 100 kDa
MWCO PES membranes ranges between 1 and 5% at flow rates of 0.5 and 1.0 μL/min.1
Considering that proteins and peptides are large in size, their aqueous diffusion coefficients are
small, thus causing mass transport through the probe to be limited resulting in lower recovery.7, 17
Another challenge for membrane science is the nonspecific adsorption of protein molecules to
the membrane surface and tubing; this decreases the effective pore size of the membrane and
thus recovery. Due to the low concentration of certain proteins in vivo, low recovery introduces
an issue of detection and quantification of these molecules.7
Use of Capture Agents in Microdialysis
Capture agents have been covalently attached to membranes previously to reduce
nonspecific adsorption, improve biocompatibility, and for removal of specific molecules.18, 19
The ideal capture agent should have both high binding capacity and a reasonably high
permeability.20 For example, quaternary amine ligands have been used for the removal of
mammalian viruses, endotoxins, and DNA for biotechnology manufacturing.21, 22 Acrylic acid
polymer brushes have also been used as a cation-exchange ligand.23 Also heparin and sulfonated
polymers imitating heparin (sulfonated poly(styrene)-b-poly(methyl methacrylate)-bpoly(styrene) and poly(vinyl pyrrolidone)-b-poly(methyl methacrylate)-b-poly-(vinyl
pyrrolidone), poly (acrylonitrile-co-acrylic acid-co-vinyl pyrrolidone)) have been used to reduce
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nonspecific adsorption, improve hemocompatibility, and promote binding of heparin binding
proteins.24-26
Theory
It has been previously shown that by adding capture agents to the perfusion fluid the
diffusive mass transport driving force across the membrane is increased. This has been shown
by including antibodies, heparin, and cyclodextrins in the perfusion fluid.1-4 These molecules
increase the diffusive mass transport driving force through the membrane due to the interaction
between the analyte and the capture agent in the fluid perfused inside the membrane, as well as
prevent nonspecific adsorption to the membrane surface.4
To understand the factors that alter a capture agent’s ability to improve relative recovery
enhancement, a hypothetical protein and affinity agent has been used of which the KD, kon, and
koff can be altered without altering the chemical structure of the protein and the affinity agent.
This allows the study of how these parameters alter the binding interaction on the interior of the
membrane surface and how these parameters alter relative recovery. It has been reported that the
enhancement in relative recovery (RR) when the affinity agent is added in the perfusion fluid is
due to the additive effect of the concentration of analyte (A) bound as shown in equation 2.5
RR =

[A]bound +[A]free
[A]external

∗ 100

[2]

This is due to the analyte affinity agent complex being collected in the perfusion fluid and also
the decrease in the concentration gradient which increases the analytes flux across the
membrane.
The amount of Abound in Equation 2 is a function of KD at equilibrium. As the KD value
decreases the amount of analyte needed to saturate the total number of binding sites decreases as
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well. This can be seen by the following chemical reaction, where the binding constant is defined
by Equation 3.
A+B AB
KD =

[A]free [B]free

[3]

[AB]

As the KD value decreases the ratio between the concentrations of analyte free in solution
compared to the analyte bound ([AB]) decreases. At a set concentration of B the binding sites
become saturated at a lower concentration at a lower KD value.
Although microdialysis is a non-equilibrium process due to the continuous flow of the
perfusion fluid, to achieve maximal relative recovery enhancement under typical low
concentration and low flux conditions for a protein the desired affinity agent should have a high
binding affinity and have a low KD value. One of the challenges with looking only at KD values
is that these values give no information about the rate at which equilibrium is reached. This
information is given by the kon and koff values. These values can be changed in such a way that
does not alter the KD values as shown in Table 1, since the KD value is equal to the koff/kon.
Table 1. On and Off Rates at a Constant KD Value.
Condition

A

B

C

D

kon (M-1s-1)

1x106

1x105

1x104

1x103

koff (s-1)

1x10-2

1x10-3

1x10-4

1x10-5

KD (M)

1x10-9

1x10-9

1x10-9

1x10-9

Under condition A the kon and koff are larger than at condition D, but with looking at only
the KD values these two conditions would appear identical. By looking at these conditions as a
function of time, the point at which equilibrium is reached is different. This can be shown using
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Equation 4 and Equation 5 for association and dissociation rate.6 When the analyte that is
binding is continually added, the association rate dominates the net rate in Equation 6, which are
the conditions that are occurring when performing microdialysis sampling in vitro.6-8
Association:

d[AB]

Dissociation:

−d[AB]

Net Rate =

dt

dt

d[AB]
dt

= k on [A]free [B]free
= k D [AB]

= k on [A]free [B]free − k off [AB]

[4]
[5]
[6]

When combining the kinetic information with the continual flux of analyte occurring
across the microdialysis probe equation 7 is formed.7 This relates the change in concentration of
the analyte free in solution as a function of time at a set area of the microdialysis probe, where J
is equal to the flux (M/s), [A]o and [B]o are the concentration of A and B free in solution, and
[AB] is the concentration of analyte bound to the affinity agent. Although Equation 4 and 5 are
in relation to the change in concentration of analyte bound these can be used to form Equation 7
because the total amount of analyte A in solution is equal to the amount of analyte A transported
across the membrane surface minus the amount bound due to the affinity interaction plus the
amount released due to the dissociation of the analyte-affinity agent complex. This equation
shows how the concentration gradient is altered by the addition of an affinity interaction on the
membrane surface.
d[A]o
dt

= 𝐽 − k on [A]o [B]o + k off [AB]

[7]

As can be seen in Equation 7 the affinity interaction in relation to kon is subtracted from the flux
term when looking at the free concentration of analyte, A, as a function of time. As the affinity
interaction becomes a more dominant term due to a high kon value the amount of free analyte in
solution approaches zero steepening the concentration gradient across the membrane surface
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which leads to an increase in mass transport across the membrane. The release of the bound
protein in terms of koff is added because the dissociation of the analyte-affinity interaction leads
to an increase in the concentration of the analyte in solution. This increase in concentration does
not affect the concentration gradient because it is carried away convectively due to the flow of
the perfusion fluid. From this equation the optimal kinetic parameters can be estimated to
determine at which kon and koff values the decrease in concentration of free analyte in solution is
maximized. This leads to an increase in the concentration gradient which alters the flux as
shown by Fick’s second law (Equation 8), where J is the flux, Deff is the effective diffusion
coefficient, l is the length, H is the partition coefficient and c is the concentration.7
𝐽=[

Deff H
l

] (C10 − C1l )

[8]

By changing the concentration gradient (C10-C1l) by lower the concentration of C1l due to
addition of a capture agent the flux across the membrane is increased due to the binding of the
analyte dominating the rate equation, shown in Equation 7.6, 9
For VEGF with a molecular weight of 15.5 kDa, a 2.5% relative recovery (from page
137), and a starting concentration outside the probe of 3,366 pg/mL the calculated flux (J) is
1.51x10-15 M/s. Assuming a total concentration of heparin 0.1 μM used in heparin affinity
microdiaysis10, the change in concentration as a function of time can be determined. Based on
the slope of that line at a set KD value of 100 nM and varying the kon and koff rates the change in
free analyte (A) over time can be plotted as shown in Figure 2.
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Figure 2. Change in concentration of A as a function of time related to the koff (s-1) and kon
(M-1s-1) at a set KD value of 100 nM.
As can be observed from Figure 2 the approximate maximal drop in the free analyte
concentration occurs approximately at a kon of 2.5 x106 M-1s-1 and koff of 0.25 s-1 with a KD of
100 nM. This leads to maximal [AB] formation which is desired because this leads to the
steepening in the concentration gradient which increases flux across the membrane At low koff
values the amount of analyte free in solution is greater due to correspondingly lower kon value
and at the higher koff values and correspondingly higher kon values the amount of analyte free in
solution calculated exceeds the amount of analyte transported across the membrane so the
concentration is equal to the flux of analyte across the membrane. Although these are the
9

predicted ideal conditions, typically an affinity interaction has either a fast kon (≥1x106 M-1s-1)
and a slow koff (≥1x10-3 s-1) and a high KD (nM) value or a slow kon (≤1x106 M-1s-1) and a fast koff
(≤1x10-3 s-1) and a lower KD (μM) value. For example, CCL2 has a reported kon of 9.97x103 M1 -1

s and a koff of 1.39x10-2 s-1 and cam-related/down-regulated by oncogenes (Domain Fn2)

(Drosophilia) has a reported kon of 1.58x105 M-1s-1 and a koff of 2.43x10-1 s-1, which have
reported fast koff but slow kon rates and μM KD values.11, 12 Also, hepatocyte growth factor has a
reported kon of 1.0x106 M-1s-1 and a koff of 1.0x10-3 s-1 and kininogen-1 has a reported kon of
1.27x106 M-1s-1 and a koff of 4.03x10-4 s-1 which have reported fast kon and slow koff rates and nM
KD values.13, 14 Two proteins which approach the ideal conditions calculated above are fibroblast
growth factor 2 and stromal cell-derived factor 1 with kon rates of 1.10x107 M-1s-1, and 2.16x106
M-1s-1 and koff rates of 4.30x10-1 s-1 and 8.30x10-2 s-1 with KD values of 3.90x10-8, and 3.84x108 15, 16

.

Antibodies
The use of antibodies as capture agents included in the perfusion fluid has been shown to
increase recovery three to twenty times.17 One of the downfalls to using antibodies is that they
are specific to only one analyte. To resolve this issue, the use of antibody-immobilized
microspheres used in flow cytometry applications were added to the perfusion fluid.17 This
allowed for multiple types of antibody-immobilized microspheres to be used, allowing for the
quantification of multiple analytes and provided a platform for quantification of the analyte.17
This method for enhanced recovery provided one disadvantage in the quantification step. If the
analyte concentration was high the microspheres became saturated and thus outside of the
calibration range of the assay meaning that the sample data was lost.17
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Heparin
Another method used to capture multiple analytes is heparin. Heparin is part of a family
of polysaccharides called glycosaminoglycans (GAG). GAG’s are a component of the tissue
extracellular matrix. In many cases, the binding of proteins to sulfated glycoconjugates, such as
heparin, have ionic character and depend on the interaction of specific positively charged
residues.18 Yet when purifying a heparin sulfate(HS)-GAG-binding protein, the protein’s
interaction with a heparin-sepharose column is distinctly different from that of a cation exchange
column of similar properties.19 Heparin on average is comprised of approximately 25
disaccharide repeating units and has an average molecular weight of approximately 16 kDa.20
Heparin contains α1–4 linked disaccharide repeat units consisting of sulfated uronic acid and
glucosamine residues, resulting in a negatively charged polydisperse linear polysaccharide.17 Its
major repeating disaccharide unit is trisulfated iduronic acid and glucosamine, but also
glucuronic acid, and N-acetyl glucosamine.20 It is postulated that the conformational flexibility
of the iduronate residue was central to the specific binding of HS-GAG oligosaccharides to a
given protein.19 Heparin is commonly used as an anticoagulant, and is typically isolated from
mast cell or mucosa.19 Heparin, has binding affinity to various growth factors such as acidic
fibroblast growth factor (aFGF), vascular endothelial growth factor (VEGF), heparin-binding
epidermal growth factor, and transforming growth factor-β (TGF-β).21 Heparin is also known to
bind to interleukin 8 (IL-8), chemokine ligand 2 (CCL2), macrophage inflammatory protein
1(MIP-1), regulated and normal T cell expressed and secreted (RANTES) and tumor necrosis
factor α (TNF-α) with nM affinity.22-25 Heparin is also known to bind thrombosponin at the TrpSer-Glu-Trp sequence present in the first type I repeat of thrombospondin. This sequence is
widely distributed in the cytokine receptor superfamily (IL3, IL4, IL6, IL7).18 Heparin-like
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materials have been shown to exhibit good blood compatibility like heparin molecules by
reducing clotting time and platelet adhesion.26-30 Using heparin-immobilized microspheres as an
additive in the perfusion fluid in microdialysis was shown to increase RR two to five fold for
aFGF, VEGF, CCL2, and CCL5 (chemokine ligand 5).31
These methods allow for increased recovery for multiple analytes. Considering that
cytokines are part of large signaling networks, the measurement of multiple cytokines rather than
just one single cytokine can provide more relevant biomedical data.17
Covalent Attachment of Capture Agents to the Membrane Surface to Increase Transport
Considering that the use of capture agents in the perfusion fluid is shown to increase RR
the question must be asked if RR could be increased by covalently attaching the capture agent to
the inside of the membrane. By covalently attaching the capture agent to the membrane
nonspecific adsorption can be reduced by adding a charged capture agent to the surface, as well
as adding a reversible binding event to the membrane surface. With PES membrane surfaces
proteins can irreversibly bind to the surface leading to membrane fouling.32-34 By reducing
irreversible binding of proteins to the surface this leads to an increase in collection of the analyte
due to the reduction in fouling.32-34 The difference between irreversible binding and reversible
binding is that reversible binding can be easily removed as compared to irreversible binding.32, 35
By adding the affinity agent to the surface this add reversible binding sites and also blocks
binding sites that would lead to irreversible binding on the membrane surface. Initially what
would be observed, if the fouling occurring on the membrane surface was the same with and
without the modification, is a decrease in the concentration of the analyte due to the binding of
the analyte dominating the rate equation shown in Equation 7 and Figure 2.6, 9
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In Equation 7 for an immobilized affinity agent, J is equal to the flux (mol/cm2 s), [A]o is the
concentration of A free in solution (mol/cm3), Bo is the moles of unbound affinity agent per cm2,
and AB is the moles of analyte bound to the affinity agent per cm2. The kon and koff rates are in
terms of (mol/cm3)-1s-1 and s-1 respectively.
For VEGF with a molecular weight of 15.5 kDa, a 2.5% relative recovery (from page
137), and a starting concentration outside the probe of 3,366 pg/mL the calculated flux (J) is
2.26x10-20 mol/cm2 s. Assuming a total amount of heparin to be 20 nmol/cm2, calculated from a
reported value of 0.3 mg/cm2 heparin bound to a polysulfone flat sheet27, the change in amount
of analyte A in moles as a function of time can be determined with various KD, kon, and koff
values as shown in Table 2, where Jo is the initial flux calculated above (2.26x10-20 mol/cm2 s,
and Ji is the flux calculated with addition of the affinity interaction.
Table 2. Change in analyte flux as a function of KD, kon, and koff values.
KD (mol/cm3)

kon (mol/cm3)-1s-1

koff (s-1)

Ji (mol cm-2s-1)

J0-Ji (mol cm-2s-1)

1 mM

100

0.1

2.26x10-20

0

100 μM

1,000

0.1

2.26x10-20

0

10 μM

10,000

0.1

2.26x10-20

0

1 μM

100,000

0.1

2.26x10-20

0

100 nM

1,000,000

0.1

2.22x10-20

4.0x10-22

100 nM

100,000

0.01

2.25x10-20

1.0x10-22

10 nM

10,000,000

0.1

1.94x10-20

3.2x10-22

10 nM

1,000,000

0.01

2.22x10-20

4.0x10-22

10 nM

100,000

0.001

2.26x10-20

0

10 nM

10,000

0.0001

2.26x10-20

0
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As shown in Table 2, with KD values in the mM to μM range the flux of the analyte is not altered
by the addition of the affinity interaction. Also with slower koff values (≤0.001 s-1) the flux of the
analyte is not altered even with nM affinity. The decrease in flux of the analyte occurs for
interactions with KD values in the nM range with koff rates of 0.01 to 0.1 s-1 and corresponding
kon rates of 1x107 to 1x105 (mol/cm3)-1s-1. This phenomenon occurs before the saturation of the
binding sites on the surface occurs. This leads to an increase in the concentration gradient which
alters the flux as shown by Fick’s second law shown in Equation 8. By changing the
concentration gradient (C10-C1l) by lower the concentration of C1l due to addition of a capture
agent the flux across the membrane is increased due to the binding of the analyte dominating the
rate equation shown in Equation 7.6, 9 Using the concentration values calculated even at the
maximum decrease concentration over time, the change in the flux would only be altered by
1.77%. This would not lead to a significant enhancement in the RR which explains why initially
before the binding sites become saturated that the RR is not altered for heparin binding proteins
(CCL2, aFGF, and VEGF).
Once the binding sites are saturated, the rate of binding and releasing of the analyte are
equal so the net rate in Equation 6 is zero. When the net rate is zero, the relative recovery is not
altered by the attachment of the affinity agent. What is interesting is that for analytes that have
affinity for heparin (aFGF, and CCL2) the relative recovery increased at later collection times
(hours 3, and 4) this could indicate that by adding reversible binding sites and the reduction in
irreversible binding sites, that the reduction in irreversible binding sites initially offsets the loss
due to binding at the surface at the earlier time points and is increasing the relative recovery at
the later time points due to saturation of the heparin binding sites. This would also explain why
the relative recovery of KC/GRO, an analyte that is not known to bind to heparin, increased for
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all collections times because the initial phase described above where association is the dominate
term in the rate equation, is not occurring.
Reducing Nonspecific Adsorption
Significance of the Nonspecific Adsorption Problem
Nonspecific adsorption is a combination of interactions that occur between two
molecules, which are driven by electrostatic, Van der Waals and other forces; however, the main
contributor to nonspecific adsorption is hydrophobic interactions.61 Nonspecific adsorption in
implantable devices used to measure the surrounding area can lead to reduced recovery, fouling
of the device, and inaccurate measurements.62-64 Membrane fouling is the term used to describe
the undesirable deposition of retained particles, colloids, macromolecules, salt etc. at the
membrane surface or inside the pores.65 Fouling of membrane devices occurs through two
mechanisms of action; the reduction of transmembrane pressure due to concentration
polarization, and the buildup of material on the surface.66 Concentration polarization leads to an
accumulation of molecules in the mass transfer boundary layer adjacent to the membrane
surface.66 This accumulation of dissolved molecules on the surface can lead to reduced solvent
activity and thus reduced solvent flow through the membrane.66 In microdialysis experiments
performed in vitro, the solution containing the analyte is typically stirred, which leads to a
decrease in concentration polarization due to the increase in convection at the membrane surface.
Importance on Nonspecific Adsorption in Microdialysis
Another challenge for microdialysis is the nonspecific adsorption of protein molecules to
the dialysis membrane and tubing, this decreases the effective pore size of the membrane and
thus recovery. PES, a commonly used as a membrane material in microdialysis is hydrophobic,
which enhances interactions with many foulants.67 PES membranes also have a high binding
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affinity for proteins and microorganisms.67 In kidney dialysis PES membranes can invoke severe
blood reactions due to adsorption and transformation of plasma proteins, activation of blood
cells, adherence of platelets and thrombosis which leads to an increased rate of mortality and
morbidity for hemodialysis patients.68 BSA, fibrinogen and other major proteins are known to
adsorb onto implanted biomaterials including microdialysis probes.69 Since calibration of the
microdialysis device is in terms of RR the recovery may be altered during or after protein
deposition, leading to an increase in the error in concentration determined based off of the RR.69
Theory of Nonspecific Adsorption
Fouling through the buildup of materials on the surface can occur through four modes of
action: adsorption, pore blockage, deposition, and gel formation.66 Adsorption occurs when
specific interactions occur between the membrane and the solute that creates a monolayer on the
surface leading to additional hydraulic resistance.66 If the degree of adsorption is concentration
dependent then the increase in concentration polarization will increase the adsorption.66 Pore
blockage can also occur, leading to a reduction in the flux due to the blocked pore.66 There are
four main mechanisms for pore blocking: complete pore blocking, internal pore blocking, partial
pore blocking, and cake filtration as shown in Figure 3.66 Deposition or cake resistance occurs
when deposited particles on the surface can grow layer by layer leading to increased hydraulic
resistance.66 Gel formation can also occur in the immediate vicinity of the membrane surface
depending on the level of concentration polarization.66 Fouling of the membrane can lead to
reduction or even loss of recovery of desired analytes.
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Figure 3. Mechanisms of fouling, (A) complete pore blockage, (B) partial pore blockage,
(C) internal pore blockage, (D) cake filtration.
Design of Nonfouling Surfaces
Highly hydrated chemical groups with optimized physical properties of the surface are
key to developing effective and stable nonfouling materials for long-term biomedical
applications.70 Polymers grafted to a hydrophobic surface can reduce protein adsorption simply
because the polymer blocked protein adsorption sites.70 Therefore, the blocking agents should
have groups which are excellent in preventing nonspecific adsorption such as hydroxyl or
poly(ethylene oxide) groups.71 The adsorption and desorption of solutes on membranes will
depend on many factors such as solution chemistry (pH, ionic strength), physiochemical
properties, operating conditions, and solution additives.71, 72 Specific surface functionalities and
not the average degree of hydrophobicity or hydrophilicity determine adsorption behavior.73 A
general observation is that proteins adsorb weakly to neutral hydrophilic surfaces, are attracted or
repelled by charged surfaces, and adsorb strongly to hydrophobic surfaces.73 The adsorption
process can be affected by the protein structure, protein stability, concentration, pH, and ionic
strength.74 The ionic strength of typical perfusion fluids used in microdialysis for Ringer’s
solution (154 mM NaCl, 5.4 mM KCl, 2.3 mM CaCl2) is 158 mM and phosphate buffered saline
(PBS) (137 mM NaCl, 10 mM Phosphate, 2.7 mM KCl) is 167.2 mM. These researchers were
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able to observe lysozyme adsorption at ionic strengths up to 100 mM.75 The adsorption of amino
acids found in proteins is influenced considerably by moieties presented in the α-position in their
structures. Hydrophilic moieties (carboxyl/amide) groups decrease amino acid adsorption on
bare silica substrates, and hydrophobic phenyl moieties increase adsorption.73
It is hypothesized that the nonfouling ability of both polyhydrophilic and polyzwitterionic
materials are tightly correlated with a hydration layer near the surface. A tightly bound water
layer forms a physical and energetic barrier to prevent protein adsorption on the surface meaning
that the energy required to displace the water is greater than the energy gained by the protein
binding to the surface. Expulsion of water from the surface is the first step in order for protein
adsorption to occur and if the surface is more hydrophilic then the water is held more tightly.70
When a protein approaches the surface, the compression of the polymer chains causes steric
repulsion to resist protein adsorption due to an unfavorable decrease in entropy.70 Bulk water is
structured because of hydrogen bonding between the water molecules.65 For hydrophobic
surfaces the orientation of water molecules in contact with a hydrophobic molecule is
entropically unfavorable.65 As a result the entropically unfavorable water molecules are expelled
into the bulk and the total free energy of the system is reduced leading ultimately to protein
adsorption.65 These hydrophobic interactions can occur up to 80 nm away.65
Reduction in Nonspecific Adsorption in Microdialysis Sampling
In microdialysis sampling, perfusion fluid additives and modifications to the membrane
have been made to reduce nonspecific adsorption. Many modifications to the perfusion fluid
have been made to increase RR by reducing nonspecific adsorption. The addition of Poloxamer
407 is one method that has been used is to modify the membrane surface.76 Poloxamer 407 is an
nonionic surfactant with a structure containing hydrophilic polyethylene glycol (PEG) regions
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and hydrophobic polypropylene glycol regions.76 These hydrophobic regions adsorbed onto the
surface exposing the hydrophilic PEG regions, reducing nonspecific adsorption by 33%.76
Albumins have also been used as a perfusion fluid additive in order to coat the tubing and the
membrane surface to reduce nonspecific adsorption leading to an increase in RR. Polysorbate 80
was also shown to reduce nonspecific adsorption of docetaxel to the polyurethane inlet tubing.77
Other perfusion fluid additives include CHAPS, -cyclodextrin, glucose, and dextran.78
Methods to Reduce Nonspecific Adsorption
Methods to reduce nonspecific adsorption focus on one of two approaches: creating a
surface that repels protein adsorption or a chemical interaction that reduces nonspecific
adsorption but for both strategies surface hydration is key to reducing nonspecific adsorption.79
One common factor of non-fouling surfaces is their resistance to the release of bound water
molecules from the surface. Water that is tightly bound to the polymer surface leads to a
separation between the proteins in solution and the polymer.79 One of the challenges with using
hydrophilic polymers is their mechanical, thermal and chemical stability.61 It has been shown
that increasing the hydrophilicity of polymers significantly reduced protein adsorption and
fouling as protein-polymer interactions are reduced.61 Many methods have been used to repel
protein adsorption by changing the properties of the surface. Some methods take the approach of
increasing the hydration of the surface, these include: zwitterionic hydrogels, PEG and
oligoethylene glycol (OEG). Other methods use blocking agents to block sites of nonspecific
adsorption from analytes of interest. There are two main types of surface modifications:
chemical and physical modifications.61 Examples of physical modifications include exposure to
flame, plasma radiation, and ion beams, and chemical modification include chemical reactions.61
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Hydrophilic Polymers
Hydrophilic surface modifications to hydrophobic membranes can reduce the
hydrophobic interaction between the protein and the polymeric membrane surface.61 It has also
been shown that polymers incorporating hydrophilic groups also showed good blood
compatibility.24 A nitrogen based plasma system has been used to modify PES membranes
making the surface more hydrophilic leading to an increase in water flux and reduced protein
fouling.80 Many other types of materials have been used to increase the hydrophilicity of the
surface by hydrogen bonding, including, tetraglyme81, dextran82, mannitol83, polyamines
functionalized with acetyl chloride84, PEG-mimetic peptoids85, and natural and synthetic
peptides.86, 87
Other Covalent Modifications to Reduce Nonspecific Adsorption
Another approach is to use adsorbed protein films. These have been shown to be
reasonable non-fouling surfaces for proteins in solution because proteins typically adsorb in
monolayers. This is caused by the retention of hydration water by adsorbed protein molecules,
preventing close interactions with the proteins in solution.79
Many different covalent modifications have been made to membranes in order to reduce
nonspecific adsorption. Photo-induced graft polymerization has been used to covalently attach a
phospholipid analog and was shown to reduce platelet adhesion to the membrane.48
Photografting has also been used to attach acrylic acid which is negatively charged over a wide
range of pH and was shown to reduce organic fouling and biofouling.88
Enzymatic Modification of Membrane Surfaces
Enzymes have also been used to facilitate the modification of membrane surfaces. The
ideal enzyme to use for modification of membrane surfaces should have low cost of production,
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inexpensive co-factors and substrates, be stable under reaction conditions, ability to exert its
catalytic activity at high reaction rates under desired reaction conditions, and broad substrate
specificity.89 One of the enzymes used to modify membrane surfaces is laccase. Laccase is an
enzyme that produces free radicals from phenolic acids using oxygen from air as an oxidant and
producing water as the only by-product.67 It is known to produce either a network or brush like
structure depending on the substrate and reaction conditions used.67
Laccase
Laccases are copper containing polyphenol oxidases that oxidize polyphenols, methoxysubstituted phenols, and diamines, and using molecular oxygen as an electron acceptor.90
Laccases induce the oxidation of C-O, C-C bonds, oxidative dimerization alicyclic esters,
hydroxystilbenes, and the combination of oxidation followed by Diels-Alder reaction.90
Laccases are more stable at or near neutral pH, and below room temperature but have a range of
stability between pH 5-8 and up to 30°C.89 Thermal inactivation is the main cause of
denaturation, refolding can occur but is slow (3-12 hours) compared to 5-60 minutes for pH
denaturation.89 Laccase Trametes versicolor has the highest redox potential among laccases (785
mV vs standard hydrogen electrode) which is correlated with high activity.89 Laccase is a
monomer, organized in three sequentially arranged domains and has dimensions of about 65 x 55
x 45 Å3.91 Laccase in nature is involved in the wound response and the synthesis of lignin.91
Laccase contains a T1 (type-1) copper and a T2, T3 copper trinuclear cluster. The T1
copper is the primary oxidation site, and the T2/T3 copper cluster being the site at which the
reduction of molecular oxygen takes place.91 The enzyme catalyzes the one-electron oxidation
of four reducing-substrate molecules followed by the four-electron reduction of molecular
oxygen to water.91 Then the reduction of molecular oxygen is accompanied by a one-electron
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oxidation of reducing substrates.91 This catalytic reaction starts with the abstraction of electrons
from the substrate by the T1 copper and subsequent reduction of the T1 Cu2+ to T1 Cu+, followed
by the internal electron transfer from T1 to the T2/T3 copper cluster, and finally the binding and
subsequent reduction of an oxygen molecule to divalent oxygen at the T2/T3 copper cluster.89
The substrate binds in a small negatively charged cavity near the copper T1 site. The negative
charges located at this site may have functional significance since they could stabilize the radical
cation products that are formed during the catalytic cycle.91 The oxygen-reducing site at the
T2/T3 cluster has access to solvent through two channels, which lead to the T2 copper and T3
copper sites.91 In between the two T3 coppers, there is an oxygen ligand, either a OH- or O-2
molecule, that coordinates with the type-2 Cu and type-3 Cu.91 The reoxidation of the coppers
occurs at a rate of 5 x106 M-1sec-1.91 The overall outcome of the catalytic cycle is the reduction
of one molecule of oxygen to two molecules of water and the concomitant oxidation of 4
substrate molecules to produce 4 radicals.91
The use of laccase to generate phenolic acid polymers and to attach phenolic compounds
to the surface of PES has been shown to reduce nonspecific adsorption and as shown in this
dissertation that it can be used to add functional groups onto the surface to covalently attach
other molecules. This is due to two reaction types that occur, the grafting reaction of monomer
onto the membrane surface and reaction of the monomers to form homopolymer in solution.92
Laccase from Trametes villosa has also been reacted with 4-hydroxybenzoic acid (4HBA) to
form a polymer with a number average molecular weight (Mn) of 8,500 Da for the 4 hour
reaction and 8,400 Da for the 24 hour reaction with a polydispersity index (PDI) of 2.06 and 2.12
for the 4 and 24 hour reaction times respectively.93 4-hydroxybenzoic acid (4HBA) has been
shown to be added to a PES surface using laccase trametes versicolor from with coverage in the

22

range of hundreds of mg/m2 which is on average more than a monolayer.94 This modification has
also been shown to reduce BSA adsorption on PES flat sheet membranes and the average flux of
the base membrane was never reduced more than 20% by the addition of the polymer.92, 94 The
reasons for these researchers choosing 4HBA is that it will add ionic and hydrogen bond-forming
properties to the PES membranes as well as there is only one hydroxyl group which leads to
growth of the chains mostly in one direction.92 At pH 4 the grafting yield after 2 hour
modification was 4 μg/cm2, at pH 5 it is 11.7 μg/cm2 and at pH 6 12.7 μg/cm2.92 This is
attributed to the ionization of 4HBA at higher pH, which leads to a lower oxidation potential, and
thus higher reaction rate and grafting yield.92 The adsorbed amount of BSA decreases with
increasing grafting yield and is close to 0 after 8 hours of modification at 28.8 mM 4HBA.92
Pycnoporus coccineus and Myceliophthore laccases have also been used to graft 4HBA to
poly(phenylene oxide)s.95 To further study the laccase catalyzed reaction these researchers
studied consumption of oxygen when laccase was in the presence of 1-naphthol using a Clarktype polarographic oxygen electrode and were able to determine KM and Vmax for the reaction.96
These were determined based on the knowledge that the initial consumption rate of dissolved
oxygen is equal to one-fourth the consumption rate of 1-naphthol due to the 1 to 4 stoichiometric
ratio in the polymerization reaction.96
Characterization of Polymer Surfaces
Many techniques are used to characterize polymer surfaces. These include techniques to
study how the physical properties of the surface are changed, how the surface is changed
chemically, and how molecules interact with the surface. Commonly studied physical properties
are hydrophobicity, thermal properties, and morphology. Techniques commonly used to study
the chemical properties of a surface are attenuated total reflectance Fourier transform infrared
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spectroscopy (ATR-FTIR), x-ray photoelectron spectroscopy (XPS), and matrix assisted laser
desorption ionization spectroscopy (MALDI). Absorption of molecules onto the surface is also
commonly measured using protein adsorption.
Techniques used to Study the Chemical Properties of a Polymer
ATR-FTIR
ATR-FTIR is a powerful technique that uses infrared spectroscopy to study the chemical
functionalities at the surface. This technique allows for the investigation of solids and liquids
without further sample preparation due to the phenomenon of total internal reflectance. This
generates an evanescent wave due to the repeated reflection of the infrared radiation interacting
on an optical crystal of high refractive index.97 This technique has been used to identify
functional groups present on surfaces, to confirm modifications made, and to study the buildup
of foulants on a surface.97 ATR-FTIR was used to confirm the synthesis of PES hollow fiber
membranes.98 Many researchers have also used ATR-FTIR to confirm a modification.52, 73, 88, 90,
99-104

Some researchers have also used ATR-FTIR to study the buildup and removal of foulants

on the surface.87, 105
XPS
XPS is an analytical technique used to characterize different chemical forms of elements
within the top 10 nm of a surface.106 Depth profiling can be performed using C60 or Ar as well as
co-sputtering with both C60 and Ar.107 Analysis of a sample is typically performed by first
performing a survey scan which is a low resolution scan used to identify the elements present in
the sample. After the survey scan, high resolution scans are performed for the specific elements
present in the sample. From these high resolution scans the different functional groups can be
seen as different peaks. Using peak fitting software, the area and intensity of these peaks can be
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determined at specific binding energies. With this information and the known response factors
for each element, the different percentages of each functional group can be calculated. This
calculation is performed by taking the area multiplied by the response factor divided by the total
of the area time response factor for all peaks. This value is then multiplied by 100 to convert to a
percentage. These percentages can then be compared. XPS has been used to monitor the
addition of coupling agents needed to induce the bond formation between a fiber and a polymer
matrix.108 XPS has been used to analyze modifications to membranes.24, 61, 90, 109, 110 By using
XPS the characteristic types of atoms and bonds for the capture agent and 4HBA will be an
indication of successful coupling.
Analysis of Polymer Samples to Determine Molecular Weight Information
Polymers formed in a polymerization reaction are by nature complex due to the
distribution of molecular weights present. One way to characterize these distributions is to
calculate the number average molecular weight (9), and weight average molecular weight (10)
which then in turn can be used to calculate the polydispersity (11),
𝑁𝑢𝑚𝑏𝑒𝑟 𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑤𝑒𝑖𝑔ℎ𝑡 =
𝑊𝑒𝑖𝑔ℎ𝑡 𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑀𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑤𝑒𝑖𝑔ℎ𝑡 =

Σ𝑁𝑥 𝑀𝑥

[9]

Σ𝑁𝑥

Σ𝐶𝑥 𝑀𝑥
Σ𝐶𝑥

𝑊𝑒𝑖𝑔ℎ𝑡 𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑀𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑊𝑒𝑖𝑔ℎ𝑡

𝑃𝑜𝑙𝑦𝑑𝑖𝑠𝑝𝑒𝑟𝑠𝑖𝑡𝑦 = 𝑁𝑢𝑚𝑏𝑒𝑟 𝐴𝑣𝑒𝑟𝑎𝑔𝑒 𝑀𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑊𝑒𝑖𝑔ℎ𝑡

[10]
[11]

where Nx is the number of molecules of Mx size, Mx is molecular weight, and 𝐶𝑥 = 𝑁𝑥 𝑀𝑥 . To
calculate these values two techniques are typically used, mass spectrometry, and size exclusion
chromatography.
Size exclusion chromatography (SEC) is a technique that separates molecules based on
their size (hydrodynamic volume) at a set solvent strength and typically a pure solvent.111 The
hydrodynamic volume depends on a variety of factors, including interactions between solvent
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and polymer molecules, chain branching, restricted rotation caused by resonance, and
conformational effects arising from the polarity, and steric bulkiness of the substituent groups.112
Unless a molar mass sensitive detector is used SEC requires calibration using standards of
known molar mass distribution. These standards are typically polyethylene, PEG or polystyrene.
In order to perform this technique, the standards need to mimic the physiochemical properties of
the sample. From these standards a calibration curve is formed from the relationship between the
log of molecular weight at peak max and the retention time.113 A commonly used detector for
SEC is a light scattering detector which is widely used for obtaining weight average molecular
weights between 10-10,000 kDa.112 A challenge for SEC is that highly branched samples have
abnormal SEC elution behavior this is due to large molecules spending too much time diffusing
in and out of the column packing creating an Argentinean bolas effect (entanglement of a part of
the macromolecule in the column packing) and sieving in the voids between packing spheres.114
One way to help with this problem is to use multiple separations for branched polymers.114 An
example of using multiple separations is to perform SEC/MALDI where the sample is
fractionated into individual fraction that have a polydispersity index (PDI) <1.07, and then
analyzed using MALDI-TOF.115 Also the information obtained from the MALDI-MS can be
used to create a calibration curve for SEC making the calibration more accurate.111 An added
advantage to using this technique is that structural data about monomers, repeating units and end
groups are also provided by SEC/MALDI.115
For polymers with molecular weights less than 50,000 Da, end group analysis, titration,
elemental analysis, radioactive tagging, and spectroscopy (IR, NMR (nuclear magnetic
resonance)), can be used to determine molecular weight information.112 In order to use end
group analysis for Mn the polymer cannot be branched.112 It also must be noted that in a linear
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polymer there are twice as many end groups as polymer molecules, and that if the polymer
contains different groups at each end of the chain and only one characteristic end group is being
measured, the number of this type is equal to the number of polymer molecules.112
When characterizing polymers using mass spectrometry, MALDI, or liquid
chromatography electrospray ionization (LC-ESI-MS) are typically used. MALDI involves
embedding the analyte in a matrix. The matrix being a compound that absorbs at the wavelength
of the laser. This energy is then transferred from the matrix to the analyte leading to ionization
of the analyte molecule as well as desorption of the matrix and the analyte. MALDI-TOF (time
of flight) MS (mass spectrometry) has been shown to be able to detect synthetic polymers in
excess of 1,000 kDa.111 One of the strengths of using MALDI-MS is in the simplicity of the
mass spectra which contains mostly singly-charged quasi-molecular ions and relatively high
tolerance for contamination.111 In order to use MALDI-MS to determine the number average
molecular weight, weight average molecular weight, and the polydispersity, the ionization
efficiency needs to be ideally the same for each molecular weight of the polymer in order for the
intensity to be used. In order for these requirements to be fulfilled there needs to be a narrowdistribution of homo-polymers with a polydispersity of approximately 1.2 or less.111 One way to
overcome the issue of complex polymer systems with several mass distributions is to use a
separation technique in conjunction with MALDI-MS.111
LC-ESI-MS can also be used to analyze polymers. ESI works by passing a liquid
through an intense electric field that disperses the sample into a fine spray into a bath gas which
evaporates the charged droplets producing gas-phase ions. These ions are then sent into the mass
analyzer. Some of the issues with using ESI for polymers are the insolubility of polymers in
ESI-compatible solvents, and their electroneutrality prohibits ion formation using the ESI
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mechanism.111 The ability of ESI to produce multiply-charged ions extends the mass range but
this can lead to complexity in the mass spectra for even narrowly dispersed polymers. To reduce
this complexity coupling the ESI to a separation technique can be done.
Techniques used to Study the Interaction between the Surface and the Environment
For surfaces that are placed in a biological sample a commonly measure parameter is
protein adsorption. Commonly used proteins solutions are bovine serum albumin (BSA),
lysozyme, and serum. Protein adsorption can be measured using a variety of methods such as
surface plasmon resonance, quartz crystal microbalance and reflectometry but these techniques
require specialized equipment. A commonly feasible method for most labs to measure protein
adsorption onto a surface is by difference between a solution containing a known protein
concentration and the surface, and a solution containing the same known concentration of
protein. This change can be measured using absorbance value at 280 nm61, 67, 92, 116-120, using the
bicinchoninic assay (BCA)121-126, or using fluorescently labeled proteins99, 103, 127, 128. Another
method is to desorb the proteins bound to the surface using sodium dodecyl sulfate (SDS) and
sodium hydroxide.87
The difference method using the absorbance at 280 nm uses the intrinsic absorbance from
aromatic amino acids present in the protein, mostly tyrosine and tryptophan.129 It is necessary to
use standards of the protein you are interested in, in our case BSA and lysozyme, because the
molar absorptivity of the each protein is different due to the different amount of aromatic amino
acids as well as how exposed those amino acids are. One of the dawbacks to this method is that
as the time of incubation of the surface with the protein solution increases, the protein denatures
exposing more of the aromatic residues which thus leads to an increase in the absorbance value
at 280 nm although the protein concentration has not changed. Another consideration that must
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be made is that other compounds can also absorb light at 280 nm. In our case the PES itself in a
solution of PBS at pH 7.4 absorbed at 280 nm. This was corrected for by performing a
measurement of a solution containing only PBS and the PES membranes. The change in
absorbance per unit area was then calculated from this information and subtracted from the
change in absorbance per unit area from the membranes placed in the protein solution.
The difference method using the BCA assay is a colorimetric assay that uses the
reduction of Cu2+ to Cu+ by proteins in an alkaline medium with detection of the Cu+ by
bicinchoninic acid.130 The first step involves the chelation of copper (Cu2+) in an alkaline
medium to form a blue complex in the presence of sodium potassium tartrate by the biuret
reaction.130 The next step involves bicinchoninic acid which reacts with the cuprous cations
formed in step one generating a purple colored product from the chelation of two molecules of
BCA with one cuprous ion.130 The BCA/copper complex displays a strong linear absorbance at
562 nm with increasing protein concentration.130 The BCA color formation is strongly
influenced by cysteine, tyrosine and tryptophan but the universal peptide backbone also
contributes to the color formation.130 BCA is dependent on the amino acid composition of the
protein therefore when using a BSA standard the concentrations are relative and not absolute.130
Also as incubation time of the surface with the protein solution increases, the protein structure
will change which can also affect the concentration calculated using the calibration curve.
Using a FITC-labeled protein to measure protein adsorption by difference, one must
consider the effect the label will have on the protein structure. FITC-labeling occurs through the
amine residues on the proteins by incubating the FITC and protein in a solution with a pH of 9.0
or greater, followed by separation of the free FITC from the FITC-labeled protein.131 The
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protein adsorption is then calculated based on the difference in fluorescence intensity from a
solution containing the surface and the solution.
Another type of method to measure protein adsorption is a method that removes the
adsorbed protein from the surface using SDS and NaOH. In this method the surface is placed in
a solution containing the protein of interest for a set amount of time.87 The surface is then
removed and placed in a solution containing SDS and NaOH which desorbs the protein bound to
the surface. Then the concentration of protein is measured in the SDS/NaOH solution.87 One of
the disadvantages to this method is that depending on the interactions between the surface and
the protein the removal with SDS and NaOH may become more or less effective. This can
become an issue when comparing a modified surface to an unmodified surface, especially if the
modification is reducing nonspecific adsorption. This can falsely lead to an increase in protein
adsorption when in fact the removal was more effective on one surface versus another.
Another factor in measuring protein adsorption is the amount of time that the surface is
incubated in the protein solutions. Commonly used incubation times are 1 hour,98, 132 2 hours,52,
99, 100

3 hours,122 and 24 hours116, 119, 120, 133.

Objective
The work to be described in this dissertation has two main objectives. The first objective
seeks to address the challenges with protein adsorption onto the dialysis membrane. This
nonspecific adsorption onto the dialysis membrane can severely affect the capabilities to recover
important signaling proteins of interest. This objective was met by covalently modifying the
membrane by attaching phenolic compounds onto the membrane and testing the RR of five
different cytokines and lysozyme. The second objective focuses on attaching an affinity agent,
heparin, onto the membrane surface, increasing the mass transport across the membrane by
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reducing irreversible adsorption. The analytes chosen are CCL2, aFGF, and VEGF. The reason
for choosing these analytes was to test if the off rates (koff) would have an effect on the RR
enhancement. The koff is defined as the rate of dissociation between two molecules with units of
s-1. CCL2 has a reported slow koff rate of (1.64 ± 0.66) x 10-3 s-1. 134 VEGF and aFGF have
reported fast koff rates of 0.10 ± 0.03 s-1 and 0.10 ± 0.03 s-1.134 Also, aFGF, CCL2, and VEGF
have different isoelectric points (pI), of 5.7, 9.3 and 8.5, respectively. Because heparin is highly
sulfonated, it is highly negatively charged, which also may be a factor in RR enhancement due to
the charge-charge interactions between the protein and heparin. Covalently attaching heparin
onto the membrane surface and measuring the change in recovery of three heparin binding
proteins has met this objective.
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CHAPTER 2. MODIFICATION OF PES FLAT SHEETS AND MICRODIALYSIS
MEMBRANES WITH 4-HYDROXYBENZOIC ACID POLYMERS TO REDUCE
NONSPECIFIC ADSORPTION AND IMPROVE RELATIVE RECOVERY

Introduction
Due to the chemical and physical stability of polyethersulfone (PES), PES is widely used
in membrane science. One of the challenges with using PES is that it is hydrophobic in nature.
For that reason, when PES is placed in a solution, it leads to an increase in nonspecific
adsorption on the surface. Previous research has shown that polymers grafted to a hydrophobic
surface can reduce protein adsorption simply by nonspecifically blocking protein adsorption
sites.70 Therefore, the polymer should have groups which prevent nonspecific adsorption, such
as hydroxyl or poly(ethylene oxide) groups.71 By modifying the surface with a hydrophilic
polymer, 4HBA, the surface becomes more hydrophilic but the chemical and physical properties
of PES are not changed. This chapter addresses a method of attaching 4HBA-initiated polymers
onto the surface using the enzyme laccase, and the characterization of nonspecific adsorption and
its effect on RR in microdialysis. Initially, experiments were performed on PES flat sheets to
confirm the modification with 4HBA polymers using the enzyme laccase, and to analyze protein
adsorption onto the surface. After characterizing this reaction onto flat sheets this method was
then applied to hollow fiber microdialysis membranes.
Materials and Methods
Materials
Laccase form Trametes versicolor, sodium acetate, fluorescein isothiocyanate dextran
4,000, fluorescein isothiocyanate dextran 10,000, fluorescein isothiocyanate dextran 20,000 and
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methyl orange were purchased from Sigma Aldrich (St. Louis, MO), 4-hydroxybenzoic acid was
purchased from TCI (Portland, OR). 3-chloro-4-hydroxybenzoic acid, and 2-5dihydroxybenzoic acid was purchased from Alfa Aesar (Haverhill, MA). HPLC grade methanol
and water were purchased from Fisher Scientific (Waltham, MA). Glacial acetic acid was
purchased from VWR international (Radnor, PA). NAP-25 Sephedex G-25 column were
purchased from GE healthcare (Chicago, IL). Bovine Serum Albumin fraction V, was purchased
from Rockland (Pottstown, PA) and was certified immunoglobulin and protease free. Lysozyme
was purchased from MP biomedicals (Solon, OH). 100 kDa PES flat sheet membranes (UE50)
were purchased from Sterlitech (Kent, WA). Fluorescein isothiocyanate isomer 1 was purchased
from Alfa Aesar (Haverhill, MA). Dibasic sodium phosphate (ACS grade) was purchased from
EMP (Howell, NJ). Sodium chloride bioXtra grade, potassium chloride (99.0%), and monobasic
potassium phosphate (ACS grade) where purchased from Sigma Aldrich (St. Louis, MO). CMA
20 microdialysis probes were purchased from Harvard Apparatus (Holliston, MA). CCL2, and
TNF- optiEIA ELISA kit was purchased from BD bioscience (San Jose, CA) Recombinant rat
KC/GRO, and mouse aFGF, and VEGF Duo set ELISA kits were purchased from R&D systems
(Minneapolis, MN).Recombinant mouse FGF1 was purchased from Sino Biologicals (Beijing,
China) and recombinant mouse VEGF was purchased from Life Technologies (Carlsbad, CA).
Addition of 4HBA onto PES Flat Sheets
Modification of 100 kDa polyethersulfone (PES) flat sheets were performed with a
solution containing 28.8 mM 4HBA or 3Cl4HBA, and 0.5 U/mL of laccase from Trametes
versicolor that were dissolved in 0.1 M sodium acetate buffer pH 5.0. The solution was filtered
using a 0.2 μm PES filter and the membranes were placed in the solution for 24 hours on a plate
shaker at room temperature. Following modification, the membranes were placed in a solution
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of 0.1 M sodium acetate buffer pH 5.0 at room temperature overnight. The membranes were
then analyzed using XPS.
XPS Methods for PES Flat Sheets
Four different control solutions were used. The 4HBA control contained 28.8 mM
4HBA in 0.1 M sodium acetate at pH 5.0. Laccase control contained 0.5 U/mL laccase in 0.1 M
sodium acetate at pH 5.0. The 3Cl4HBA control contained 28.8 mM 3Cl4HBA in 0.1 M sodium
acetate at pH 5.0. Sodium acetate control contained only 0.1 M sodium acetate at pH 5.0. The
procedure for the controls was the same as the modified flat sheet membranes. Three 1 cm x 1
cm flat sheet 100 kDa PES membranes was placed in these solutions and each one was analyzed
individually. Then one from each group of flat sheet membranes was analyzed in three different
areas. XPS high resolution spectra for C1s, O1s, and Cl 2p, and survey scans were performed.
ATR-FTIR Method
A separate set of membranes where prepared as stated above but allowed to react in the
4HBA polymerization solution for 1, 2, 3, and 4 days. The membranes were then placed in a
desiccator overnight to dry the membrane before analysis with the ATR-FTIR.
Protein Adsorption Methods
FITC-labeling of both BSA and lysozyme was performed by placing 400 μg of FITC into
10 μL of DMSO, and dissolving 4 mg of BSA or lysozyme into 990 μL of 0.1 M phosphate at
pH 8.0. These two solutions were then combined and incubated at 37°C for 2 hours. Then, the
solution was filtered using a NAP-25, Sephedex G-25 size exclusion column to separate the
FITC-labeled protein from the free FITC. The concentration of FITC-labeled protein was
determined based on the absorbance at 280 nm. Later, the membranes were then placed in a
solution of FITC-BSA (74 μg/mL) or FITC-lysozyme (5.5 μg/mL) and a solution without
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membranes (control solution) were incubated for 48 hours. Then, fluorescence measurements
were made using an excitation wavelength of 485 nm, and the emission was measured from 500650 nm. As a result, the emission maxima were between 517 nm and 520 nm for FITC-BSA and
for FITC-lysozyme were between 515 nm and 517 nm. To determine the concentration, a
calibration curve was made for both FITC-BSA and FITC-lysozyme using the stock solutions
from above. After the concentration was determine, the difference between the concentration of
the control solution and the solution containing the membranes was calculated. Then, the
difference was used to determine the amount of protein adsorbed per unit of surface area using
Equation 12.
𝑃𝑟𝑜𝑡𝑒𝑖𝑛 𝐴𝑑𝑠𝑜𝑟𝑝𝑡𝑖𝑜𝑛 (𝜇𝑔⁄𝑐𝑚2 ) =

𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (𝜇𝑔⁄𝑚𝐿)∗𝑣𝑜𝑙𝑢𝑚𝑒 (𝑚𝐿)
𝑆𝑢𝑟𝑓𝑎𝑐𝑒 𝐴𝑟𝑒𝑎 (𝑐𝑚2 )

[12]

Attachment of 4HBA onto Microdialysis Membranes
For the modification of the PES microdialysis membranes a solution containing 28.8 mM
of 4HBA, and 0.5 U/mL of laccase from Trametes versicolor that was dissolved in 0.1 M sodium
acetate buffer pH 5.0. Then, the solution was filtered using a 0.2 μm PES filter and perfused at a
rate of 1 μL/min for either 2 hours or 24 hours. Following modification, the probe was flushed
with 0.1 M sodium acetate buffer pH 5.0 overnight at a flow rate of 3 μL/min. Following
modification, the microdialysis membranes were either used for a relative recovery experiment
or cut longitudinally and the inside was analyzed for reaction with 4HBA using XPS. An initial
survey scan was performed to determine the elements present in the sample. This was followed
by high resolution scans of C1s, O1s and S2p to determine the binding energies present and the
percentages of those binding energies.
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Relative Recovery Determination
FITC-Dextrans
Initially an experiment was performed to determine if the presence of laccase alters the
membrane in a way that changes the recovery of FITC-4 and FITC-10. The microdialysis probes
were placed in a stirred solution containing 0.5 U/mL laccase in sodium acetate pH 5 for 2 hours,
and perfused for 2 hours in laccase solution. Relative recovery of FITC-4 and FITC-10 was
determined using a CMA 20 microdialysis probe at a flow rate of 1 μL/min with a perfusion fluid
of 4% (w/v) Dextran 500 in Ringer’s solution (154 mM NaCl, 5.4 mM KCl, and 2.3 mM CaCl2)
at pH 7.2-7.4. The probe was placed in a solution of either 500 μM FITC-4 or 200 μM FITC-10
in perfusion fluid and samples were collected every 20 minutes for a total of 60 minutes. Then,
the absorbance values were measured in triplicate for each sample at 493 nm, and concentrations
were determined based off a calibration curve measured that day.
To test the impact of the modification with 4HBA, FITC-4, FITC-10 and FITC-20 RR
was determined. This experiment was performed using a CMA 20 microdialysis probe modified
for 0, 2 and 24 hours with 4HBA at a flow rate of 1 μL/min using PBS at pH 7.4. The solution
the probe was placed in contained 500 μM FITC-4, 200 μM FITC-10 or 100 μM FITC-20 in PBS
pH 7.4, and samples were collected every 20 minutes for a total of 60 minutes. Absorbance
values were measured in triplicate for each sample at 493 nm, and concentrations were
determined based off a calibration curve measured the same day.
Proteins
After testing RR of FITC-4, FITC-10, and FITC-20, RR was analyzed for lysozyme using
control, 2 hour and 24 hour 4HBA modified membranes using the same microdialysis probes as
above. RR of lysozyme was performed using 500 μg/mL of lysozyme with a perfusion fluid of
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PBS at pH 7.4 at a flow rate of 1 μL/min. Samples were collected every 30 minutes for a total of
2 hours and were analyzed using a standard BCA assay. Next RR of CCL2, VEGF, TNF-,
KC/GRO (keratinocyte chemoattractant/ growth regulated oncogene), and aFGF were
performed. To test the RR of these analytes the probes were placed in a solution containing
6,000 pg/mL of CCL2, 800 ng/mL of aFGF, 4,000 pg/mL KC/GRO, 5,000 pg/mL TNF- or 200
ng/ml of VEGF in PBS 0.1% BSA at pH 7.4. These concentrations were chosen in order to
observe concentrations in the dialysate that are within the detection range for the corresponding
ELISA. The perfusion fluid was prepared using PBS 0.1 % BSA at pH 7.4 and perfused at 1
μL/min, and the samples were collected every hour and analyzed using a standard CCL2, aFGF,
KC/GRO, TNF- or VEGF ELISA.
Results and Discussion
Addition of 4HBA Polymers onto PES Flat Sheets
After modification with 4HBA and laccase using the procedure described above, images
of the membrane were taken. As shown in Figure 4, upon the addition of 4HBA polymer onto
the PES flat sheets the membrane surface becomes browner in color which is due to the
oxidation of the 4HBA polymer on the surface. The results from XPS analysis are shown in
Figure 5 and Tables 3 and 4. In Figure 5(A), the high resolution scan of C1s shows the presence
of 3 peaks for the 4 different controls (laccase control, 4HBA control, 3Cl4HBA control, and
sodium acetate control); these are the C-C/C-H peak at 284.77 eV, the ether linkage (C-O-C) at
286.23 eV and the C-S peak at 288.81 eV. For the 4HBA modified and 3Cl4HBA modified,
there is a peak present between C-O-C and C-S which corresponds to the carboxylic acid
functional group at 287.85 eV. This indicates that the membrane is modified because the
controls (4HBA control, laccase control, 3Cl4HBA control, and sodium acetate control) do not
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contain carboxylic acid functional groups. In Figure 5(B), the Cl2p high resolution scan showed
the presence of C-Cl peak at 200.32 eV and 201.92 eV which indicates the attachment of
3Cl4HBA. Also, the C-Cl peaks are not present in the 3Cl4HBA control indicating the
3Cl4HBA does not adsorb to the surface, but is covalently bound. In Figure 5(C), the O1s high
resolution survey scan shows the presence of 2 peaks for the 4 controls; these are from the O-C
(531.72 eV) and O-S (533.35eV) functional groups. In the 4HBA and 3Cl4HBA modified flat
sheet membranes, there is a merging of these 2 peaks indicating the presents of a third functional
group, possibly a carboxylic acid functional group. In Figure 5(D), the survey scan for the
4HBA modified, 3Cl4HBA modified and the sodium acetate control is shown. From the
information obtained from the high resolution spectra, the percentages of each functional group
was calculated and tabulated in Table 3 for one flat sheet analyzed in 3 different areas and in
Table 4, for 3 different flat sheets.
For the laccase control, the C-C, C-O-C, O-C and O-S percentages were significantly
different than the other control membranes. This is most likely due to laccase being a protein,
and proteins are known to adsorb onto PES surfaces. For the 4HBA modified membranes, due to
the O-S bond only being present in PES, the O-S decreased. For 4HBA, the COOH functional
group was also present which is the end group of the 4HBA polymer at a percentage of
8.62±0.74%. For 3Cl4HBA, the C-Cl doublet was present a percentage of 3.50±0.71% and
1.75±0.36%, the COOH functional group was present at 5.10±1.63% and the O-S decreased.
Results in Table 4, for three different locations on one flat sheet show similar trends to the results
in Table 3 indicating uniformity in the modification procedure. For the 4HBA modified flat
sheets, the COOH functional group appeared at a percentage of 6.82±2.19% which was not
present in any other control flat sheets. Also, the O-S and C-O-C functional group was
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significantly less than the control membranes. For the 3Cl4HBA modified membranes, the
chlorine doublet for C-Cl was present at a percentage of 2.88±0.24% and 1.44±0.12%, and the
COOH functional group at 5.10±1.82%. Also, the C-O-C percentage increased and the O-S
environments decreased compared with the control membranes.

A

B

C

D

E

F

G

H

Figure 4. PES membranes before and after 4-hydroxybenzoic acid modification. (A) PES,
(B) sodium acetate control, (C) laccase control, (D) 4HBA control, (E) 1 day 4HBA
modification, (F) 2 day 4HBA modification (G) 3 day 4HBA modification, (H) 4 day 4HBA
modification.

39

A

Laccase Control
3Cl4HBA Control
4HBA Control
Sodium Acetate Control
24 Hour 4HBA Modified
24 Hour 3Cl4HBA Modified

8000

C-H/C-C

6000

B
1200

Laccase Control
3Cl4HBA Control
4HBA Control
Sodium Acetate Control
24 Hour 4HBA Modified
24 Hour 3Cl4HBA Modified

C-Cl

1000

c/s

c/s

800

4000

600

C-O
C-S
400

COOH
2000

200

0
295

0
290

285

280

275

210

205

Binding Energy (eV)

C

Laccase Control
3Cl4HBA Control
4HBA Control
Sodium Acetate Control
24 Hour 4HBA Modified
24 Hour 3Cl4HBA Modified

5000

O-S
4000

200

195

190

Binding Energy (eV)

D
50000
45000
40000

O-C

Sodium Acetate Control
24 Hour 4HBA Modified
24 Hour 3Cl4HBA Modified

35000

c/s

c/s

3000

30000
25000

2000

20000
15000

1000

10000
5000

0
544

542

540

538

536

534

532

530

Binding Energy (eV)

528

526

524

0
1400

1200

1000

800

600

400

200

0

Binding Energy (eV)

Figure 5. XPS spectra for PES flat sheets. XPS overlays for high resolution scans of C1s
(A), Cl2p (B), and O1s (C), and XPS survey scan overlay (D) for PES flat sheets.
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Table 3. PES flat sheet membranes analyzed using XPS in three different areas on one flat sheet membrane. Percentages are
determined from the peak areas of the C 1s, O 1s, and Cl 2p high resolution XPS spectra. The element listed first indicates the
source of the photoelectron. * indicates a significant difference from the sodium acetate control, 4HBA control, and 3Cl4HBA
control at the 95% confidence level using a single factor ANOVA with Bonferroni post hoc test. ND indicates not detected
(≤0.1).

Binding
Energy
(eV)
Sodium
Acetate
Control
4HBA
Control
3Cl4HBA
Control
Laccase
Control
4HBA
Modified
3Cl4HBA
Modified

C-C

C-O-C

C-S

COOH

O-C

O-S

Cl-

Cl-

C-Cl

C-Cl

284.77±0
0.093

286.23
±0.093

288.81
±0.09

287.85
±0.14

531.72
±0.19

533.35
±0.12

197.92
±0.07

199.52
±0.07

200.32
±0.04

201.92
±0.04

55.32
±3.33%

13.89
±0.95%

7.79
±0.95%

ND

12.54
±0.96%

10.46
±1.07%

ND

ND

ND

ND

57.25
±0.78%
51.28
±3.86%
47.00
±5.47%*
58.66
±5.01%
53.02
±4.53%

11.00
±4.26%
14.88
±1.51%
23.28
±0.89%*
11.77
±1.55%
17.69
±2.51%*

7.20
±0.79%
9.00
±0.60%
8.51
±0.57%
3.53
±1.15%*
1.12
±0.02%*

ND

13.09
±1.43%
13.77
±1.47%
14.06
±4.39%*
14.44
±6.89%
12.53
±1.95%

9.41
±1.40%
11.40
±1.04%
7.15
±1.32%*
3.62
±1.40%*
6.24
±1.45%*

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

0.14
±0.012%*

0.077
±0.005%*

3.50
±0.71%*

1.75
±0.36%*

ND
ND
8.62±
0.74%*
5.10±
1.63%*
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Table 4. Three PES flat sheet membranes analyzed using XPS. Percentages are determined from the peak areas of the C 1s, O
1s, and Cl 2p high resolution XPS spectra. The element listed first indicates the source of the photoelectron. * indicates a
significant difference from the sodium acetate control, 4HBA control, and 3Cl4HBA control at the 95% confidence level using
a single factor ANOVA with Bonferroni post hoc test. ND indicates not detected (≤0.1).

Binding
Energy
(eV)
Sodium
Acetate
Control
4HBA
Control
3Cl4HBA
Control
Laccase
Control
4HBA
Modified
3Cl4HBA
Modified

C-C
284.77
±0.02

C-O-C
286.24
±0.07

C-S
288.83
±0.10

COOH
287.95
±0.12

O-C
531.69
±0.24

O-S
533.31
±0.31

Cl197.86
±0.01

Cl199.46
±0.07

C-Cl
200.35
±0.04

C-Cl
201.95
±0.03

51.07
±0.90%

15.58±
1.36%

8.35±
0.71%

ND

14.43
±2.57%

10.56
±2.38%

ND

ND

ND

ND

51.00
±4.86%
49.32
±2.86%
46.62
±3.76%
56.63
±2.14%
49.13
±6.49%

15.49
±0.22%
16.17
±1.31%
20.38
±3.60%*
12.06
±2.24%*
19.62
±2.94%*

7.99
±1.48%
8.57
±0.45%
8.07±
0.47%
3.64
±1.21%*
0.81
±0.45%*

ND

14.65
±0.97%
15.34
±1.73%
17.08
±0.43%
12.67
±1.90%
14.68
±4.86%

10.88
±2.68%
10.60
±0.45%
7.84
±0.38% *
7.36
±1.55% *
7.06
±4.33% *

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND
ND
6.82
±2.19%*
5.10
±1.82%*

0.22
0.11
2.88
±0.091%* ±0.044%* ±0.24%*

1.44
±0.12%*
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Figure 6. IR spectra of the PES side of the flat sheet membrane for PES, 1 day
modification, 2 day modification, 3 day modification, 4 day modification after attachment
of 4-hydroxybenzoic acid polymers.
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Figure 7. IR spectra of the PET side of flat sheet membrane for PES, 1 day modification, 2
day modification, 3 day modification, 4 day modification after attachment of 4hydroxybenzoic acid polymers.
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The ATR-FTIR spectra in Figure 6 show the presence of a hydroxyl peak from the
conjugated carboxylic acid functional group at 3300 cm-1 for the PES side of the membrane.
This peak increases in size as the modification time increase. The polyethylene terephthalate
(PET) side of the membrane in Figure 7 shows that it is unaffected by the 4HBA modification.
The presence of the carboxylic acid functional group is evidence of the attachment of 4HBA
polymers on the PES surface. The combined results from XPS and IR confirm the attachment of
4HBA polymers on the surface of PES flat sheets.
Protein Adsorption Experiments
After confirming the attachment of 4HBA onto PES flat sheets, the amount of BSA and
lysozyme adsorbed onto the surface was measured. This was done to investigate whether the
modification would reduce nonspecific adsorption of BSA and lysozyme. Lysozyme was chosen
because of its isoelectric point (pI) of 11, which makes the overall charge on the protein at pH
7.4 positive; BSA was chosen because its pI is 4.7, which makes the overall charge on the
protein at pH 7.4 negative. Since the 4HBA polymer introduces a carboxylic acid functional
group (pKa=4.54) onto the surface which is deprotonated at pH 7.4, the comparison of the
amount of BSA and lysozyme adsorbed onto the surface can give insight into the dominate
mechanism of protein adsorption upon addition on the 4HBA polymer. Reduction in protein
adsorption can occur through charge repulsion and by strengthening the water polymer
interaction.70 If BSA adsorption decreases and lysozyme increases, a charge-charge interaction
dominates. This is due to the carboxylic acid being deprotonated at pH 7.4 so lysozyme would
be attracted to the surface and BSA would be repelled. However, if BSA and lysozyme
adsorption decrease then the water-polymer interaction dominates. This is due to water being
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more tightly bound to the surface due to the interaction with the carboxylic acid functional group
and the water must be displaced in order for proteins to adsorb to the surface.
Initially both BSA and lysozyme were fluorescein isothiocyanate (FITC) labeled. After
FITC labeling BSA and lysozyme, the membranes were placed in a solution of FITC-BSA (74
μg/mL) or FITC-lysozyme (5.5 μg/mL). Then the difference between a solution without the
membrane and with the membrane was used to determine the amount of protein adsorbed onto
the surface. This was performed for the following reasons: 1) to determine if the modification
with 4HBA altered the amount of protein adsorbing to the surface, and 2) investigate the
dominate mechanism (charge attraction/repulsion, water polymer interaction) of protein
adsorption.
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Figure 8. BSA () and lysozyme () adsorption onto PES membranes modified with 4hydroxybenzoic acid (4HBA) polymers for between 1 and 24 hours compared to control
membranes. * indicates significant difference at the 95% confidence level compared to the
0 hour reaction time using a single factor ANOVA with Bonferroni post hoc test. The error
bars represent the standard deviation in protein adsorption calculated from 3 different
solutions containing PES membranes modified with 4HBA for different reaction times.
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The results for FITC-lysozyme adsorption, shown in Figure 8, show an increase in the
adsorption of FITC-lysozyme after 4HBA modification. In addition, the results for the FITCBSA experiment, shown in Figure 8, show an initial increase in BSA adsorption which becomes
significant at the 4 hour of reaction time followed by a decrease in BSA adsorption after 8 hours
of reaction time. At a 24 hour reaction time, FITC-BSA adsorption is significantly lower
compared to the control. For BSA, the initial increase in protein adsorption could be due to the
graft density of the polymer on the surface which is not sufficient enough to exclude BSA. This
could be due to the BSA being able to go between the polymer chains, and BSA becoming
trapped within the chains of the polymer which will lead to an increase in protein adsorption.
Moreover, the decrease in protein adsorption observed at the 24 hour reaction time is due to the
exclusion of BSA from becoming trapped within the polymer chains due to the increase in size
and graft density with the longer reaction time. At increased graft density there are more
carboxylic acid functional groups which could increase charge-charge repulsion, leading to a
decrease in BSA adsorption. For lysozyme, the increase in protein adsorption is possibly caused
by the 4HBA modification’s ability to trap lysozyme because lysozyme is smaller at 14 kDa
compared to BSA at 66.5 kDa. Also, the increase in lysozyme adsorption could be due to the
charge-charge interaction with the deprotonated carboxylic acid functional group. Overall this
experiment shows that for BSA, there is a decrease in protein adsorption with the 24 hour
reaction time, but for lysozyme there is an overall increase in protein adsorption due to a
combination of graft density and charge-charge interactions between the polymer and the
protein.
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Modification of Microdialysis Membranes with 4-Hydroxybenzoic Acid Polymers
Following the confirmation of the covalent attachment of 4HBA polymers onto PES flat
sheet, the reaction was applied to PES microdialysis membranes. The attachment of 4HBA
polymers onto the microdialysis membranes was confirmed using XPS. Then, RR values of
FITC-labeled dextrans of 4 kDa, and 10 kDa, were determined to analyzed the effect of the
reaction on transport as well as the effect of nonspecific adsorption of the reactants (4HBA and
laccase). Finally, RR of lysozyme, CCL2, VEGF, KC/GRO, TNF-, and acidic fibroblast
growth factor (aFGF) was determined and compared to unmodified microdialysis probes.
XPS Characterization
The results from XPS analysis for both control and 24 hour 4HBA modified membranes
(Table 4) show the presence of the carboxylic acid functional group at 287.90 ± 0.17 eV with
9.73 ± 5.94%. There is also a decrease in the O-S functional group at 532.99 ± 0.88 eV from
3.15 ± 0.64% to not detectable values. There is also a decrease in S2p which is only found in
PES from 3.12 ± 1.14% to 0.85 ± 0.18%. This confirms the attachment of 4HBA polymer onto
to the microdialysis membrane because 4HBA is the only source of the carboxylic acid
functional group. Also, the decrease in O-S, and S2p, only found in PES, shows the addition of
polymer onto the surface is sufficient to not allow the photoelectrons from O-S to escape.

49

Table 5. XPS data from control and 24 hour 4HBA modified microdialysis membranes.
Percentages are determined from the peak areas of the C1s, O1s, and S2p high resolution
XPS spectra. N=3, * indicates a significant difference from the control at the 95%
confidence level using a single factor ANOVA with Bonferroni post hoc test. ND indicates
not detected (≤0.1%).

eV
Control
4HBA
Modified

C-C/C-H
284.71 ±
0.11
54.65 ±
10.40%
49.83 ±
11.88%

C-O
285.98 ±
0.30
22.54 ±
6.76%
17.68 ±
6.50%

COOH
287.90 ±
0.17
ND
9.73 ±
5.94%*

S2p
168.09 ±
0.25
3.12 ±
1.14%
0.85 ±
0.18%*

O-C
531.63 ±
0.57
15.14 ±
5.07%
14.81 ±
4.36%

O-S
532.99 ±
0.88
3.15 ±
0.64%*
ND

Effect of Laccase and 4-Hydroxybenzoic Acid on the Relative Recovery of FITC-4 and FITC-10
FITC-4 and FITC-10 RR of three different microdialysis probes were analyzed to
determine if nonspecific adsorption of laccase onto the surface would alter the transport across
the membrane. Results shown in Figure 9 and 10 show that FITC-4 and FITC-10, RR is not
significantly different, indicating that laccase does not adsorb to the microdialysis membrane in a
way that inhibits the RR of FITC-4 and FITC-10. This indicates that laccase is not adsorbing
onto the surface to an extent that would inhibit the transport of FITC-4 and FITC-10.
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Figure 9. Analysis of the effect of nonspecific adsorption of laccase on FITC-4 relative
recovery. Three different groups were analyzed, control probes perfused and placed in a
solution that does not contain laccase, probes perfused with a 0.5 U/mL laccase solution,
and probes placed in a solution containing 0.5 U/mL of laccase. These results correspond to
3 different probes tested for RR of FITC-4 at 3 different times, with each time point
measured in triplicate. Error bars represent ± SD from mean.
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Figure 10. Analysis of the effect of nonspecific adsorption of laccase on FITC-10 relative
recovery. Three different groups were analyzed, control probes perfused and placed in a
solution that does not contain laccase, probes perfused with a 0.5 U/mL laccase solution,
and probes placed in a solution containing 0.5 U/mL of laccase. These results correspond to
3 different probes tested for RR of FITC-10 at 3 different times, with each time point
measured in triplicate. Error bars represent ±SD from mean.
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FITC-4, FITC-10, FITC-20 Relative Recovery after 2 and 24 Hour Reaction Time
Next, FITC-4, FITC-10, and FITC-20 RR was tested after modification with 4HBA and
laccase for 2 and 24 hours. This was performed to see if the modification would hinder the RR
of these molecules. The results from this experiment are shown in Figures 11-13. For FITC-4
(Figure 11), there is a 20% decrease in RR after modification for 2 hours and a 61% decrease for
the 24 hour modification time. For FITC-10 (Figure 12), the RR decreased by 40% for the 2
hour modification and 73% for the 24 hour modification. FITC-20 (Figure 13) showed a 40%
decrease for the 2 hour modification time and a 76% decrease for the 24 hour modification. For
the 2 hour modification time, there is only a slight decrease, of 20%, in RR of FITC-4 which
then increases to 40% for FITC-10 and FITC-20. Moreover for the 24 hour modification, FITC4, FITC-10 and FITC-20 RR decrease by approximately 70%. This could indicate that the longer
modification time leads to denser polymer formation. This leads to an increase in pore blockage
which decreases RR.
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Figure 11. FITC-4 relative recovery for control, 2, and 24 hour 4HBA modified
microdialysis probes. N=3, * indicate significant difference at the 95% confidence level
using a two factor ANOVA with Bonferroni post hoc test.
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Figure 12. FITC-10 relative recovery for control, 2, and 24 hour 4HBA modified
microdialysis probes. N=3, * indicate significant difference at the 95% confidence level
using a two factor ANOVA with Bonferroni post hoc test.
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Figure 13. FITC-20 relative recovery for control, 2, and 24 hour 4HBA modified
microdialysis probes. N=3, * indicate significant difference at the 95% confidence level
using a two factor ANOVA with Bonferroni post hoc test.
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Relative Recovery of Lysozyme
After observing the reduction in FITC-4, FITC-10 and FITC-20 RR by modification with
4HBA, lysozyme was tested to investigate if the reduction of the RR would occur by comparing
protein and dextran RR. Lysozyme is a 14 kDa protein but is more globular in structure
compared to dextran which is more linear.135, 136 Figure 14 shows that there is no significant
reduction in lysozyme RR for the 2 hour 4HBA modified microdialysis probes, but for the 24
hour 4HBA modified microdialysis probes the lysozyme concentration were below the detection
limit of 25 μg/mL with a 500 μg/mL solution outside the probe. This suggests that pore blocking
and/or charge-charge attraction is occurring after 24 hours of modification with 4HBA and
laccase.
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Figure 14. Lysozyme relative recovery for control, 2 hour, and 24 hour 4HBA modified
microdialysis probes. Probes were placed in a solution containing 500 μg/mL of lysozyme.
ND indicates not detected (detection limit of 25 μg/mL), N=3.
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Relative Recovery of CCL2, VEGF, KC/GRO, aFGF, and TNF-α
After measuring the RR of lysozyme, the RR of CCL2, aFGF, KC/GRO, TNF-, and
VEGF were measured. The reason for choosing these analytes is due to their varying molecular
weights as well as isoelectric points shown in Table 6. The 4HBA modification introduces a
carboxylic acid functional group, which is deprotonated at pH 7.4, onto the membrane surface.
Different analytes may interact differently with the surface based on the charge-charge
interactions between the protein and the membrane surface. Also by varying molecular weight,
recovery enhancement may be altered due to the change in size of the pores based on the
modification time. For these experiments, 2 hour and 24 hour 4HBA modified membranes will
be compared with control microdialysis probes.

Table 6. Molecular weight and isoelectric point (pI) values for proteins whose relative
recoveries were analyzed.
Protein

Molecular Weight (kDa)

pI

TNF-α

17.2

5.0

aFGF

15.5

5.7

VEGF

21

8.5

KC/GRO

7.8

9.1

CCL2

13.1

9.3
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Figure 15. Box and whiskers plot of CCL2 relative recovery of control and 2 hour 4HBA
modified microdialysis probes. N=6 The box represents the 25th-75th percentiles. The line
through the box represent the median, whiskers represent the 5th and 95th percentile, and
the □ represents the mean. * Indicates significantly different than the control at the 95%
confidence level (p≤ 0.05) as determined by a 2 factor ANOVA with Bonferroni post hoc
test.
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Figure 16. Box and whiskers plot of CCL2 relative recovery of control and 24 hour 4HBA
modified microdialysis probes. N=6 Significance was compared between the control and
24 hour 4HBA modified microdialysis probes and the control at the 95% confidence level
as determined by a 2 factor ANOVA with Bonferroni post hoc test.
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For CCL2, the 2 hour modification showed a significant increase in RR between 90 and
190 % (Figure 15). For the 24 hour modification, CCL2 RR did not increase significantly
overall (Figure 16). CCL2 is a 13.1 kDa protein so it is similar in molecular weight to lysozyme
at 11 kDa. The lack of RR increase could be due to partial pore blockage which was observed
with the FITC-labeled dextrans. Also, the isoelectric point of CCL2 is 9.25 which gives the
protein an overall positive charge. This could explain the increase in RR for the 2 hour 4HBA
modified membranes because CCL2 could bind to the surface due to the overall negative charge
provided by the carboxylic acid functional group added by 4HBA. However, this was not
observed in the 24 hour modified membranes due to the partial blockage of pores due to the
increase in size and/or graft density with a longer modification time.
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Figure 17. Box and whiskers plot of VEGF relative recovery of control, 2 and 24 hour
4HBA modified microdialysis probes. N=3 * Indicates significantly different than the
control at the 95% confidence level as determined by a 2 factor ANOVA with Bonferroni
post hoc test.

A comparison of RR for VEGF between control and 4HBA modified membranes is
shown in Figure 17. This figure shows an increase in RR for the 2 hour 4HBA modification but
not for the 24 hour modification. This absence of an increase in RR for the 24 hour 4HBA
modification could be due to the pores size becoming reduced because of the longer modification
time.
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Figure 18. Box and whiskers plot of KC/GRO relative recovery of control, and 2 hour
4HBA modified microdialysis probes. N=3 * Indicates significantly different than the
control at the 95% confidence level as determined by a 2 factor ANOVA with Bonferroni
post hoc test.

KC/GRO is a 7.8 kDa protein with an isoelectric point of 9.1. KC/GRO relative recovery
was analyzed because at pH 7.4 the protein has an overall positive charge. As seen with CCL2
and VEGF which also have isoelectric points above 7.4, the relative recovery increased upon
modification with 4HBA for 2 hours. In Figure 18, the relative recovery of KC/GRO was shown
to increase by the addition of the 4HBA polymer after modification for 2 hours. This is
consistent with the increase in relative recovery after modification with 4HBA for 2 hours for
proteins with isoelectric points above 7.4.
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Figure 19. Box and whiskers plot of aFGF relative recovery of control, 2 and 24 hour
4HBA modified microdialysis probes. N=3 * Indicates significantly different than the
control at the 95% confidence level as determined by a 2 factor ANOVA with Bonferroni
post hoc test.
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Figure 20. Box and whiskers plot of TNF-α relative recovery of control, 2 hour 4HBA
modified microdialysis probes. N=3 * Indicates significantly different than the control at
the 95% confidence level as determined by a 2 factor ANOVA with Bonferroni post hoc
test.

For aFGF, there was a significant increase in RR at hour 4 between the control and 2 hour
4HBA modified membranes (Figure 19). CCL2 (13.1 kDa) is slightly smaller than aFGF (15.5
kDa), and also aFGF has an overall negative charge based on the isoelectric point (pI 5.6). The
charge-charge repulsion between aFGF, and 4HBA could explain the lack of RR increase. RR of
TNF-α a 17.2 kDa protein with an isoelectric point of 5.0 was analyzed for the 2 hour 4HBA
modification. The RR for TNF- after 2 hour 4HBA modification, as shown in Figure 20, was
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not significantly different than the control RR this could be due to charge-charge repulsion
between the negatively charged surface and TNF-α which has an overall negative charge.
For CCL2, VEGF, and KC/GRO the RR increased for the 2 hour modification. RR did
not increase with the 2 hour 4HBA modification for aFGF and TNF-α. This RR increase was not
observed for CCL2 and VEGF for the 24 hour modification time. For aFGF the increase in RR
was only observed at hour 4 for the 2 hour modification time. TNF-α and aFGF have isoelectric
points of 5.0, and 5.7 compared to CCL2, VEGF, and KC/GRO at 9.3, 8.5, and 9.1. The
modification adds a negative charge onto the surface by the carboxylic acid functional group.
Being that aFGF and TNF-α have an overall negative charge there may be charge repulsion
between the protein and the surface. For CCL2, VEGF, and KC/GRO the overall positive charge
may introduce charge attraction between the protein and the surface. This could lead to the
larger increase in RR due to the attractive force between CCL2, VEGF, and KC/GRO.
Conclusions
This chapter shows successful attachment of 4HBA polymers onto flat sheet and
microdialysis membranes using both XPS and ATR-FTIR data. BSA adsorption onto PES flat
sheet shows an initial increase followed by a decrease in BSA adsorption that becomes
significant at 24 hours. For lysozyme the adsorption increased upon addition of 4HBA polymers
onto the surface. RR experiments using FITC-labeled dextrans showed a decrease in RR for the
24 hour reaction time of approximately 70% and a slight decrease for the 2 hour reaction time.
The RR experiment for lysozyme showed no significant difference for the 2 hour modification
time but was not detectable for the 24 hour modification time. For CCL2, VEGF, and KC/GRO
the 2 hour reaction time showed a two to three fold increase in RR for the 2 hour 4HBA
modification.
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CHAPTER 3. COMPARISON OF PROTEIN ADSORPTION METHODS

Introduction
Many researchers are quantifying protein absorption onto surfaces to improve
implantable devices as well as membrane purification devices. Nonspecific adsorption of
proteins can lead to reduced recovery across the membrane surface, fouling of the device and
inaccurate measurements.62-64 Protein adsorption is a commonly measured parameter to
determine the effectiveness of their device or treatment, but many different methods are used to
determine the amount of protein adsorbed.137 When making a comparison between different
modifications to a surface, one must consider the fact that protein adsorption may be measured
using different methods. This can make comparing reported results from different methods
difficult.
Materials and Methods
Materials
Bovine Serum Albumin fraction V, was purchased from Rockland (Pottstown, PA) and
was certified immunoglobulin and protease free. Lysozyme was purchased from MP
biomedicals (Solon, OH). 100 kDa PES flat sheet membranes (UE50) were purchased from
Sterlitech (Kent, WA). Fluorescein isothiocyanate isomer 1 was purchased from Alfa Aesar
(Haverhill, MA). Dimethyl sulfoxide was purchased from Electron Microscopy Sciences
(Hatfield, PA). Sodium hydroxide was purchased from Mallinckrodt Chemicals (St. Louis,
MO). Sodium dodecyl sulfate was purchased from J. T. Baker (Phillipsburg, NJ). Dibasic
sodium phosphate (ACS grade) was purchased from EMP (Howell, NJ). Sodium chloride
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bioXtra grade, potassium chloride (99.0%), and monobasic potassium phosphate (ACS grade)
where purchased from Sigma Aldrich (St. Louis, MO).
Protein Adsorption Measured by Absorbance at 280 nm and BCA Assay
PES flat sheet membranes of approximately 25 cm2 were cut into pieces of approximately
1 cm2 and placed in a solution containing either 0.5 mg/mL or 0.25 mg/mL of BSA or lysozyme
in PBS (137 mM NaCl, 2.7 mM KCl, 10.1 mM Na2HPO4, 1.8 mM KH2PO4) pH 7.4. The
solution was placed on a plate shaker and samples were then collected from the solution after 2,
24, 48 and 72 hours. Then, an absorbance value at 280 nm was measured and samples were also
analyzed using a standard BCA assay.130
Protein Adsorption Measured by Removal with SDS and 0.05 M Sodium Hydroxide
PES flat sheet membranes of approximately 5 cm2 were cut into pieces of approximately
1 cm2 and placed in a solution containing 4.5 mg/mL of either BSA or lysozyme in PBS pH 7.4.
The solution was placed on a plate shaker and the membranes were removed from the solution
after 2, 24, 48 and 72 hours and placed in a solution containing 2 wt % SDS and 0.05 M NaOH
for 2 hours.87 An aliquot was then removed and an absorbance value at 280 nm was measured.
This value was then compared to a calibration curve of known BSA and lysozyme concentrations
in 2 wt% SDS and 0.05 M NaOH.
Protein Adsorption Measured using FITC-labeled Proteins
FITC-Labeling BSA and Lysozyme
FITC-labeling of both BSA and lysozyme was performed by placing 1 mg of FITC into
10 μL of DMSO, and dissolving 10 mg of BSA or lysozyme into 990 μL of 0.1 M phosphate at
pH 8.0. These two solutions were then combined and incubated at 37°C for 2 hours. The
solution was then filtered using a NAP-25 Sephedex G-25 column to separate the FITC-labeled
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protein and the free FITC. The concentration of FITC labeled protein was determined based on
the absorbance at 280 nm.
Protein Adsorption Measurements
For the FITC-BSA adsorption experiment PES flat sheet membranes were placed in a
solution containing 74 μg/mL of FITC-BSA in PBS pH 7.4 and allowed to incubate for 2, 24, 48
or 72 hours. Then, the solution was removed and the fluorescence intensity measured using an
excitation wavelength was 485 nm and the emission was measured from 500-650 nm. The
emission maxima for FITC-BSA after incubation with the PES membranes were between 517
nm and 520 nm. For FITC-lysozyme, the membranes were placed in a solution containing 5.5
μg/mL of FITC-lysozyme in PBS pH 7.4. The emission maxima were between 515 nm and 517
nm for FITC-lysozyme after incubation with the membrane. To determine the concentration a
calibration curve was made for both FITC-BSA and FITC-lysozyme from the stock solutions
above. The concentration in μg/mL was then converted to μg/cm2 based on the sum of the
surface areas of the membrane pieces and the volume of the solution.
Results and Discussion
Protein Adsorption Measured by Absorbance at 280 nm and BCA Assay
Initially an experiment was performed using a surface areas differing by tenfold
(approximately 1 cm2 and 10 cm2). The difference in concentration between the solution with
the membrane and without the membrane was non-detectable for both the 280 nm, and BCA
assay detection methods using incubation times of 2, 24, and 48 hours. To combat the issue of
not being able to detect the difference in concentration between the solution with the membrane
and without the membrane, the total surface area was increased to approximately 25 cm2. Two
aliquots of the solution (with and without membranes) were used for the BCA and absorbance at
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280 nm detection methods. The membranes were also incubated in a solution containing either
0.5 mg/mL or 0.25 mg/mL of BSA or lysozyme. A comparison between the two methods is
shown in Table 7 and 8 for BSA and lysozyme.
Table 7. Comparison of BCA and 280 nm for BSA (0.50 mg/mL, 0.25 mg/mL). Symbol
indicates significantly different at the 95% confidence level as compared to ND(*) and 24
hour time point (#).
Detection
Concentration 2 hours
Method
(μg/cm2)
ND
Absorbance 0.50 mg/mL
at 280 nm
0.25 mg/mL
ND
BCA

24 hours
(μg/cm2)
22.88±11.90*

48 hours
(μg/cm2)
43.96±21.97*

72 hours
(μg/cm2)
ND

16.44±3.38*

40.22±4.51*#

32.35±1.66*#

0.50 mg/mL

ND

ND

4.49 ±1.69*

3.80±1.95*

0.25 mg/mL

ND

ND

ND

3.32±1.48*

For BSA protein adsorption measured using the detection method of absorbance at 280
nm; there was no significant difference between amount of protein adsorbed per unit surface area
for the 24 hour and 48 hour incubation time. There was also no significant difference at the 72
hour incubation time for the BCA detection method. For the 72 hour incubation time, the
amount of protein adsorbed measured by the absorbance change at 280 nm was non-detectable
for the BSA concentration of 0.5 mg/mL, but it was detectable for the 0.25 mg/mL
concentration. For the BCA detection method the amount of protein adsorbed onto the surface
was detectable for the 0.5 mg/mL BSA concentration but non-detectable for the 0.25 mg/mL
BSA concentration. The 2 hour incubation showed non-detectable amounts of protein adsorbed
for both the absorbance at 280 nm and BCA detection methods. The 24 hour incubation time
also showed a non-detectable amount of protein adsorbed using the BCA method but showed
detectable amounts using the absorbance at 280 nm. Between the absorbance at 280 nm and
BCA detection methods at the 48 hour incubation time using the 0.50 mg/mL concentration of
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BSA was not significantly different. At the 72 hour incubation time the methods were compared
using the 0.25 mg/mL concentration and showed a significant difference between the two
methods. As can be seen in Table 7 incubation time affects protein adsorption measurements as
well as the concentration of the protein used. Also, protein adsorption calculated using the
absorbance at 280 nm is significantly larger than that calculated from the same solution using the
BCA method. This could be due to these methods measuring different properties of the
molecules and possible interference in measuring the absorbance at 280 nm. The difference
method using the absorbance at 280 nm uses the intrinsic absorbance from aromatic amino acids
present in the protein, mostly tyrosine and tryptophan.129 The BCA assay is a colorimetric assay
that uses the reduction of Cu2+ to Cu1+ by proteins in an alkaline medium with detection of the
Cu1+ by bicinchoninic acid.130
Table 8. Comparison of BCA and 280 nm for Lysozyme (0.50 mg/mL, 0.25 mg/mL). *
indicates difference as compared to ND.
Detection
Concentration 2 hours
Method
(μg/cm2)
ND
Absorbance 0.5 mg/mL
at 280 nm
0.25 mg/mL
ND
BCA

24 hours
(μg/cm2)
ND

48 hours
(μg/cm2)
16.60±6.21*

72 hours
(μg/cm2)
12.39±3.23*

5.13±3.50*

18.94±2.45*

16.84±12.46*

0.5 mg/mL

ND

ND

ND

9.23±4.51*

0.25 mg/mL

ND

3.33±1.50*

4.99±2.56*

4.90±1.45*

For lysozyme (Table 8), there is no significant difference between the 48 hour and 72
hour incubation period for absorbance at 280 nm and for 72 hours BCA detection method. Since
there was no significant difference between the concentrations of lysozyme for the BCA and
absorbance 280 nm detection methods individually, the data was pooled to compare the protein
adsorbed using the two detection methods. There was found to be no significant difference
between the BCA and 280 nm detection methods at the 72 hour time point; data was pooled for
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the comparison of methods. For 24 hour and 48 hour time points, the data for the 0.25 mg/mL
concentration was used for comparison and showed no significant difference in the methods for
the 24 hour incubation time, but at the 48 hour incubation time the difference is significant. For
lysozyme for the absorbance at 280 nm and BCA assay 72 hours of incubation in necessary to
detect protein adsorption. Lysozyme protein adsorption determined using the BCA and
absorbance at 280 nm detection method also showed different protein adsorption values for
different incubation times as well as different concentrations. This again could be due to the
different properties of the molecule and possible interference using the absorbance at 280 nm.
Comparison of Protein Adsorption Methods using Detection Methods of Absorbance at 280
nm, BCA Assay, FITC-Labeled Proteins, and a Removal Method using SDS and NaOH
To compare with the removal method using SDS and NaOH, and FITC-labeling, the 0.25
mg/mL protein concentration was used for the BCA and absorbance at 280 nm detection
methods. Table 9 shows the comparison of the different methods using BSA. For the BCA assay
detection method the protein adsorption, is non-detectable until 72 hours of incubation with the
protein solution. Table 10 shows a comparison of different detection methods for lysozyme.
The amount of protein adsorbed was non-detectable for the 2 hour incubation time for the
absorbance at 280 nm and BCA detection methods.
A comparison between the different detection methods for each incubation was
performed. For the 2 hour incubation time, the BCA and absorbance at 280 nm methods showed
non-detectable amount of BSA adsorbed on the surface. For the 24 hour incubation time, the
removal method with SDS and NaOH showed significantly different protein adsorption than the
other three methods (absorbance at 280 nm, BCA, and FITC-BSA) and also the BCA detection
method showed non-detectable concentration of BSA adsorption. For the 48 hour incubation
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time, the FITC-BSA method was significantly different compared to the absorbance at 280 nm
and removal method with SDS and NaOH. Also, the removal method with SDS and NaOH was
significantly different than the absorbance at 280 nm detection method. For the 72 hour
incubation period, the removal method with SDS and NaOH was significantly different than the
other three detection methods; the absorbance at 280 nm was significantly different than the
BCA, and FITC-BSA detection methods.
Next a comparison was made for each method within each incubation time. For the
removal method with SDS and NaOH, the 2 hour incubation time was significantly different than
the other three incubation times. The absorbance at 280 nm detection method showed a
significant difference between the 24 hour incubation time and the 48 and 72 hour incubation
times. At the 2 hour incubation time, protein adsorption was non-detectable for the absorbance
at 280 nm detection method. For the BCA assay detection method, the 72 hour incubation was
the only incubation time to show detectable protein adsorption. The FITC-BSA detection
method showed a significant difference between the 2 hour and 24 hour incubation time, the 24
hour and 48 hour incubation time, and the 72 hour incubation time with the 2, 24, and 48 hour
incubation times.
For lysozyme a comparison was made between each detection method within each
incubation time. For the 2 hour incubation time, the removal method with SDS and NaOH and
FITC-lysozyme were significantly different, and for the absorbance at 280 nm and BCA assay
showed non-detectable values of protein adsorbed onto the surface.
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Table 9. Comparison of methods to measure BSA adsorption at various time points using
the protein adsorption methods by difference using detection methods of absorbance at 280
nm, BCA assay, and FITC-labeled BSA methods and removal method using SDS and
NaOH. SDS (*) 280 nm (#), BCA (^), and FITC-BSA(~)indicates significantly different at
the 95% confidence level compared to detection listed next to symbol. ND=not detected.
Method
SDS/NaOH
280 nm
BCA Assay
FITC-BSA

2 hours
(μg/cm2)
12.27±2.83~
ND
ND
5.70±0.41*

24 hours
(μg/cm2)
89.07±26.46#~
16.44±3.38*
ND
7.90±0.14*

48 hours
(μg/cm2)
69.07±2.21~
40.22±4.51*~
ND
6.74±0.66*

72 hours
(μg/cm2)
73.01±15.05#^~
32.35±1.66*^
3.32±1.48*#
9.15±0.10*#

Table 10. Comparison of methods to measure lysozyme adsorption at various time points
using the protein adsorption methods by difference using detection methods of absorbance
at 280 nm, BCA assay, and FITC-labeled BSA methods and removal method using SDS
and NaOH. SDS (*) 280 nm (#), BCA (^), and FITC-lysozyme(~) indicates significantly
different at the 95% confidence level compared to detection listed next to symbol. ND=not
detected.
Method
SDS/NaOH
280 nm
BCA Assay
FITC-Lys

2 hours
(μg/cm2)
34.05±6.43~
ND
ND
0.33±0.35*

24 hours
(μg/cm2)
15.25±5.20#^~
5.13±3.50*
3.33±1.50*
0.61±0.14*

48 hours
(μg/cm2)
17.70±2.73^~
18.94±2.45^~
4.99±2.56*#
0.36±0.10*#

72 hours
(μg/cm2)
20.59±4.00~
16.84±12.46
4.90±1.45
0.72±0.13*

Then, for the 24 hour incubation time there was a significant difference between the SDS and
NaOH removal method compared to the other three detection methods (BCA assay, absorbance
at 280 nm, and FITC-lysozyme). For the 48 hour incubation time, the absorbance at 280 nm was
significantly different than the BCA assay and FITC-lysozyme detection methods, and the
removal method with SDS and NaOH was significantly different than the BCA assay and FITClysozyme detection methods. The 72 hour incubation time showed a significant difference
between the removal method with SDS and NaOH and FITC-lysozyme.
Next a comparison was made between incubation time for each method. For the
absorbance at 280 nm and the BCA detection methods the 2 hour incubation time was
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significantly different than the 24, 48 and 72 hour incubation time. Then, for FITC-lysozyme, 2
hour and 72 hour incubation times were significantly different; for the removal method with SDS
and NaOH the 2 hour incubation time and the 24 and 48 hour incubation times were significantly
different.
The absorbance at 280 nm and removal with NaOH and SDS showed significantly higher
protein adsorption than the BCA and FITC-labeled protein detection methods. This could be due
to the SDS/NaOH removal method using the absorbance at 280 nm as the detection method to
quantify protein adsorption. The absorbance at 280 nm could have interference from other
molecules in the solution. The FITC-labeled protein and removal method with NaOH and SDS
showed detectable protein adsorption values for all incubation times. Being that the removal
method with SDS and NaOH is dependent on the interactions between the surface and the
protein the removal with SDS and NaOH may become more or less effective. This can become
an issue when comparing a modified surface to an unmodified surface especially if the
modification is reducing nonspecific adsorption. This can falsely lead to an increase in protein
adsorption when actually the removal was more effective for one surface compared to another.
Conclusions
When comparing protein adsorption values reported in the literature, it is necessary to
consider what methods they used to determine protein adsorption. Different methods, even
when analyzing the same sample, can give significantly different protein adsorption values this is
shown, in Table 7 and 8, that the BCA method and the absorbance at 280 nm method for
lysozyme and BSA. Incubation time and detection methods can also be a factor in comparing
protein adsorption values.
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CHAPTER 4. CHARACTERIZATION OF LACCASE REACTION WITH 4HYDROXYBENZOIC ACID

Introduction
Determination of the structure and molecular weight distribution of the polymer that is
added to the PES membrane surface is important to understanding the protein adsorption
properties of the polymer. Understanding of the structure of the polymer such as the structure of
the chains in terms of branching, the size, and molecular weight distribution can give insight
about the transport across the membrane. Others have reported using gel permeation
chromatography the number average molecular weight (Mn) of 8,500 Da and a weight average
molecular weight (Mw) of 17,550 Da for a 4 hour reaction time on the reaction of 4HBA with
laccase, Trametes villosa. This is a different species than the Trametes versicolor enzyme that is
used in this dissertation.93 The polymerization reaction between laccase from Trametes
versicolor, 3-chloro-4-hydroxybenzic acid (3Cl4HBA) and 4HBA were characterized to
determine the distributions of molecular weights present at different polymerization times. This
information provides insight into the modification that is occurring on the PES membrane
surface.
Materials and Methods
Materials
Laccase form Trametes versicolor, sodium acetate, fluorescein isothiocyanate dextran
4,000, and methyl orange were purchased from Sigma Aldrich (St. Louis, MO), 4hydroxybenzoic acid was purchased from TCI (Portland, OR). 3-chloro-4-hydroxybenzoic acid,
and 2-5-dihydroxybenzoic acid was purchased from Alfa Aesar (Haverhill, MA). HPLC grade
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methanol and water were purchased from Fisher Scientific (Waltham, MA). Glacial acetic acid
was purchased from VWR international (Radnor, PA). NAP-25 Sephedex G-25 column were
purchased from GE healthcare (Chicago, IL). Amicon Ultra centrifugal filters of 3, 10, and 50
kDa molecular weight cut-off were purchased from EMD Millipore (Billerica, MA).
HPLC-UV Experiment to Separate Monomer from Polymer
An initial experiment was performed to see if using high performance liquid
chromatography (HPLC) with an ultraviolet (UV) detector, the monomer (4HBA or 3Cl4HBA)
could be separated from any formed polymer. First the reaction of 28.8 mM 3Cl4HBA and
4HBA in the presence of 0.5 U/mL of laccase in sodium acetate buffer pH 5.0 was allowed to
react for 1 and 2 hours. After the specified reaction time, 2 mL of the 10 mL total sample was
then centrifuged using a bench top centrifuge for 2 minutes. The precipitate was then collected
and dissolved in 500 μL of 75% methanol/25% water and half of this sample was then filtered
through a 0.2 μm syringe filter. Then, the samples were analyzed using the HPLC-UV using a
C18 5 μm column, solvent of 65% methanol/35% water at a flow rate on 1 mL/min for 20
minutes, at a wavelength of 254 nm.
MALDI-TOF
To further analyze the polymer a polymerization solution with 0.5 U/mL of laccase and
28.8 mM 4HBA in sodium acetate pH 5 in a total volume of 2 mL was made. Then, a 90 μL
aliquot of the solution was added every 15 minutes to a conical tube containing 10 μL of 10%
acetic acid to reduce the pH to 2 and halt the reaction for a total of 3 hours. The samples were
then filtered through a 10 kDa molecular weight cut-off centrifugal filter to remove the laccase
enzyme. Each sample was then diluted by 50% with 1 M 2,5-dihydroxybenzoic acid in water
and then spotted on a MALDI plate in triplicate.
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Separation of Polymer from Monomer using Molecular Weight Cut-Off Filters and
Analyzing the Effluent using HPLC
To determine the molecular weight of the polymer, a separation technique was performed
using centrifugal filters with Amicon Ultra 3, 10 and 50 kDa molecular weight cut-off. This was
in order to see if the polymer would be excluded by one of these MWCO filters and to give an
approximate molecular weight range of the synthesized polymer. The filtrate collected was then
analyzed on the HPLC-UV. A modification solution containing 28.8 mM 4HBA and 0.5 U/mL
of laccase was allowed to react for 24 hours. Then, 500 μL samples were collected and placed in
either a 3, 10 or 50 kDa MWCO centrifugal filter and centrifuged at 14,000 x g for 30 minutes.
The filter was then inverted and placed in a new microcentrifuge tube which was centrifuged at
1,000 x g for 2 minutes. The samples where then diluted 1 to 100 in 50% methanol/water and
were injected onto the HPLC-UV with a mobile phase of 50% acetonitrile/water and a flow rate
of 1 mL/min.
Gel Permeation Chromatography (GPC) Separation of 4HBA Polymer Solution
GPC was performed to gain a better understanding of the molecular weight distribution
of the polymer present. This experiment was performed on a reaction mixture that was allowed
to react for 3 days. The 4HBA precipitate solution was made by taking 2 mL of the
polymerization solution and centrifuging for 8 minutes at 13,500 rpm. The solution was
decanted and the precipitate was reconstituted in 500 μL of sodium acetate pH 5.0 for each 1 mL
aliquot, and then the two aliquots were combined. Then the NAP-25 Sephedex G-25 column
(exclusion limit of 5,000 Da) was conditioned with 4 mL of 0.1 M sodium acetate pH 5.0 and
either 1 mL of the 4HBA polymer solution or the reconstituted precipitate was loaded onto the
column. Then, 0.1 M sodium acetate pH 5.0 was added to the column to continue the flow and
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samples were collected in 1 minute intervals, equaling a sample volume of approximately 1.5 mL
per minute, for a total of 21 minutes for the 4HBA precipitate solution and for 15 minutes for the
4HBA polymerization solution.
HPLC-UV Analysis of GPC Effluent
After performing GPC above the experiment was repeated and samples were collected
every 15 seconds using the method described above. Samples 4 (4.25 minutes), 5 (4.5 minutes),
14 (7.25 minutes), 15 (7.5 minutes), and 16 (7.75 minutes) at the apex of the two peaks were
selected for HPLC-UV analysis. Each sample was diluted 1 to 10 with acetonitrile. Then, 20 μL
samples were in injected onto the column with a mobile phase of 50/50 acetonitrile/water at a
flow rate of 1.5 mL/min. The UV detector was set at 254 nm using a Restek Ultra C18 5 μm
column.
Calibration of GPC with Methyl Orange and FITC-4
This experiment was performed using the reaction mixture of 28.8 mM 4HBA with 0.5
U/mL of laccase from Trametes versicolor after 24 hours. After the NAP-25 Sephedex G-25
column was conditioned with 4 mL of 0.1 M sodium acetate pH 5.0, 1 mL of the 4HBA polymer
solution was loaded onto the column. Then, 0.1 M sodium acetate pH 5.0 was loaded onto the
column, and samples were collected in 30 second intervals for a total of 25 minutes. Then, the
absorbance values of the samples were measured at 280 nm and 250 nm. Next solutions of
fluorescein isothiocyanate (FITC-4) (4,389 Da) and methyl orange (327 Da) were loaded onto
the column, and samples were collected using the procedure described above. The absorbance
measurements were made at 460 nm and 494 nm for methyl orange and FITC-4 solutions.
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GPC of 4-Hydroxybenzoic Acid Solution
The purpose of this experiment was to determine the molecular weight distribution of the
4HBA polymer formed in solution. This was done using a GPC column with an exclusion limit
of 5,000 Da. This experiment was performed using the reaction mixture of 28.8 mM 4HBA with
0.5 U/mL of laccase from Trametes versicolor after 2 and 24 hours. After the NAP-25,
Sephedex G-25 column was condition with 4 mL of 0.1 M sodium acetate pH 5.0, 1 mL of the
4HBA polymer solution was loaded onto the column. Then, 0.1 M sodium acetate pH 5.0 was
loaded onto the column, and samples were collected in 30 second intervals for a total of 12.5
minutes. The absorbance values of the samples were measured at 280 nm and 250 nm. Also, a
solution of 0.6 mg/mL of 4HBA (monomer) was analyzed.
Direct Infusion-Mass Spectrometry Methods
Three groups of samples were prepared, one with a buffer of 0.1 M sodium acetate pH
5.0, one with 0.1 M ammonium acetate pH 5.0, and one prepared with water. Also 28.8 mM
4HBA was made in each one of the solvents and another with 28.8 mM 4HBA and 0.5 U/mL
laccase. First, the 4HBA and the 4HBA with laccase solutions, and a solution containing the
solvent (blank) were passed through a NAP-25 column with the corresponding solvent and
samples were collected from minute 5 to minute 10. The samples were then diluted 1,000 fold
with HPLC grade water. These samples were then analyzed using direct infusion at a flow rate
of 0.05 mL/min into an electrospray quadrupole ion trap mass spectrometer with a solvent of
methanol with 0.1% formic acid.
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Results and Discussion
HPLC-UV Experiment to Separate Monomer from Polymer
To detect polymer formation an experiment was designed to analyze the monomer and
the polymerization solution after 1 and 2 hour reaction times. The samples collected were
centrifuged and precipitate collected. The precipitate was then diluted in the mobile phase (75%
methanol/water) was filtered through a 0.2 μm filter. Both of these samples were then analyzed
on the HPLC-UV. In Figure 21, the results for the reaction with 4HBA are shown, and in Figure
21 the results for the reaction with 3Cl4HBA are shown. Both reaction mixtures show the
presence of an initial peak at approximately 2.5 to 3 minutes which contains the monomer and
possibly polymers that retain on the column similar to the monomer. This is confirmed by the
retention time being similar to the monomer (4HBA, 3Cl4HBA) shown below. The next peak at
approximately 8 minutes for the 1 hour reaction and 11 minutes for the 2 hour reaction is the
polymer. Further analysis on these peaks was performed to confirm the identity of the first peak
as the monomer and identify the molecular weight of the polymer using MALDI-TOF.
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Figure 21. HPLC results for 4-hydroxybenzoic acid with laccase for a 1 and 2 hour
reaction times as well as a solution of 4-hydroxybenzoic acid (0.288 mM 4HBA).
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Figure 22. HPLC results for 3-chloro-4-hydroxybenzoic acid with laccase for 1 and 2 hour
reaction times, and a solution of 3-chloro-4-hydroxybenzoic acid (0.288 mM 3Cl4HBA).
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MALDI-TOF to Determine Polymer Characteristics
Analysis on the 4HBA modification solution and the precipitate formed in the
polymerization reaction was analyzed using MALDI-TOF mass spectrometry to determine the
molecular weight of the polymer. Being that the monomer (4HBA) is very similar in structure to
the matrix 2,5-dihydroxybenzoic acid, the 4HBA was not distinguishable from the multimers
formed from the matrix. This also made it difficult to determine what was 4HBA polymer as
well.
Separation of Polymer from Monomer using Molecular Weight Cut-Off Filters and
Analyzing the Effluent using HPLC
Next an experiment was designed to separate the polymer from the monomer using 3, 10,
and 50 kDa molecular weight centrifuge filters; based on the presence of the polymer one could
determine a molecular weight range of the polymer. The results from this experiment, in Figure
23, show no significant change in the retention time; although, the intensity increased with
increasing molecular weight cut-off. This could indicate that more of the polymer is allowed
through the 50 kDa filter than the 10 and 3 kDa filters, showing that some of the polymer is
being excluded by the filter; although, not all of the polymer is excluded.
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Figure 23. HPLC results for 4HBA polymerization solution concentrate solutions collected
from 3, 10, and 50 kDa molecular weight centrifugal filters. The inset is the HPLC
chromatogram from 1 to 3.5 minutes.
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Gel Permeation Chromatography (GPC) Separation of 4HBA Modification Solution
To further characterize the size distribution of the polymer formed when 4HBA reacts
with laccase; the reaction mixture was passed through a gel permeation chromatography (GPC)
column. GPC is a technique that separates molecules based on their size, as compared to
reversed phase HPLC with a C18 column which separates molecules by their polarity. With
proper calibration, this method can be used to determine the number average and weight average
molecular weights as well as the polydispersity. The purpose of this experiment was to separate
the polymer formed from the monomer. Two different samples were analyzed using at NAP-25
Sephedex G-25 GPC column: 4HBA polymer solution (Figure 24) and the reconstituted
precipitate (Figure 25).
The conclusions from this experiment are that for the polymerization solutions (Figure
24) there are 2 regions of polymer of different molecular weight which can be seen by the two
peaks at the 250 nm wavelength. Also, there is a peak shown by the absorbance at 280 nm that
elutes between these 2 peaks at 250 nm. The NAP-25 column has an exclusion limit of 5 kDa.
Considering the enzyme is 55 kDa; the enzyme itself is more than likely not eluting at minute 6.
This peak could possibly be polymer forming that absorbs at 280 nm. For the reconstitute
precipitate (Figure 25), there is only one peak present between minute 4 and minute 9 at 250 nm
as compared to the 4HBA polymerization solution that has 2 peaks present in that time frame.
This difference could be due to the decrease in the intensity of the peak for the precipitate sample
or an increase in the species that is eluting at the 7 minute time point.
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Figure 24. Absorbance values for aliquots collected every minute for 15 minutes from a
NAP-25, Sephedex G-25 column loaded with 1 mL of the polymerization solution.
Absorbance at 280 nm and 250 nm were measured.
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Figure 25. Absorbance values for aliquots collected every minute for 21 minutes from a
NAP-25, Sephedex G-25 column loaded with 1 mL of the reconstituted precipitate.
To further analyze the fractions collected with GPC, HPLC analysis was performed. This
was in order to see if the initial peak for 4HBA decreased and the suspected polymer peak
increased with increasing elution time on the GPC column.
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Table 11. HPLC-UV analysis of GPC fractions showing retention time and peak area at an
absorbance value of 254 nm.

4 (4.25 minutes)

Peak 1
Retention Time
(minutes)
0.406

2,138,076

Peak 2
Retention Time
(minutes)
1.382

5 (4.5 minutes)

0.408

4,022,054

1.398

42,172

14 (7.25 minutes)

0.432

3,136,303

1.407

52,218

15 (7.5 minutes)

0.421

2,239,927

1.397

82,700

16 (7.75 minutes)

0.417

1,578,258

1.398

80,093

Fraction (time)

Peak Area

Peak Area
61,846

The results from this experiment (Table 11) show the presence of a peak at approximately
0.4 minutes and a smaller peak at approximately 1.4 minutes. Considering that samples 4-5 and
14-16 were from two different regions in the GPC experiment shown in Figure 24, but eluted at
the same time for the HPLC experiment, indicates that the two sets of polymers are of very
similar chemical structure but are different in size. For the initial peak, there is an initial increase
in the area followed by a decrease in area after fraction 5. This indicates that there is more
monomer and/or small polymer in the initial samples. For the second peak the area for the later
fractions (15, 16) is larger than the initial samples (4, 5) this indicates that there an increase in
larger polymer in the later samples than the initial samples. This could be an indication that the
polymer is not following size exclusion behavior because larger polymer should elute (in earlier
fractions) before smaller polymer. In this experiment, the opposite is observed because the
smaller polymer elutes in earlier fractions than does the larger polymer. This could be due to the
branched nature of the polymer becoming trapped in the column material leading to a longer
retention time.
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Calibration of GPC with Methyl Orange and FITC-4
The experiment was then repeated with a 24 hour polymerization reaction with methyl
orange and FITC-4 used to calibrate the GPC column. The results from this experiment are
shown in Figure 26. The conclusion from this experiment is that the 24 hour polymerization
solution has a similar GPC elution profile to the 3 day polymerization solution. Also from this
experiment, the polymers formed in solution are between the molecular weights of 4,389 Da
(FITC-4) and 327 Da (methyl orange).
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Figure 26. Gel permeation chromatography experiment performed using a NAP-25
Sephadex G-25 column (exclusion limit of 5 kDa) for 24 hour 4HBA polymer solution,
methyl orange solution, and FITC-4 solution.
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GPC of 4-Hydroxybenzoic Acid Solution
In this experiment the monomer (4HBA) and laccase solutions were loaded onto the
column to look at their elution behavior compared to the polymer. As shown in Figure 27 and 28
the laccase solution is not of sufficient concentration to absorb at 280 nm and shows no
observable peaks that would interfere with the peaks observed for the monomer (4HBA) or the
polymer. Also the monomer elutes as the first peak which shows that the 4HBA polymers do not
follow size exclusion behavior because the smaller species, the monomer, elutes first. This
information makes it difficult to predict the molecular weight of the polymer using this method.
Typically for SEC the larger molecules elute first followed by the smaller molecules. This could
be due to the highly branched nature of this polymer which can lead to abnormal SEC elution
behavior due to large molecules spending too much time diffusing in and out of the column
packing creating an Argentinean bolas effect (entanglement of a part of the macromolecule in the
column packing) and sieving in the voids between packing spheres.114 In order to further
understand the molecular weights present in the solution samples were analyzed using direct
infusion-MS.
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Figure 27. Gel permeation chromatography experiment performed using a Sephadex G-25
column (exclusion limit of 5 kDa) for 2 and 24 hour 4HBA polymer solution reaction times
4-hydroxybenzoic acid, and laccase at 250 nm.
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Figure 28. Gel permeation chromatography experiment performed using a Sephadex G-25
column (exclusion limit of 5 kDa) for 2 and 24 hour 4HBA polymer solution reaction times,
4-hydroxybenzoic acid, and laccase at 280 nm.
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Direct Infusion-Mass Spectrometry Experiment
For the direct infusion mass spectrometry experiments, three different sample solutions
were used: water, 0.1 M sodium acetate buffer pH 5.0 and 0.1 M ammonium acetate buffer pH
5.0. Sodium acetate and ammonium acetate at pH 5.0 were chosen due to the conditions
required for the polymerization reaction to occur and water was chosen to eliminate the salt
interference for the monomer solution even though the polymerization reaction does not occur in
water. These solutions were then passed through the GPC column and analyze in the mass
spectrometer. The results from this experiment were inconclusive due to high background noise
from the blank samples shown in Figure 29 (A), 30 (A), and 31 (A). For the solutions containing
4HBA (Figure 29 (B, C), 30 (B, C), and 31 (B, C)) a peak corresponding to phenol (m/z 92.6)
could be observed. This is from the decarboxylation of 4HBA in the ESI source. The
ammonium acetate buffer shows the least background. Polymer formation could not be detected
in the 4HBA and laccase solutions as there were no peaks present in significant quantity that
were not present in the background or the 4HBA solution. This could be due to polymerization
of the monomer in the ESI ionization source.138 Also for the polymerization solution the
formation of a large amount of small concentrations of a heterogeneous mixture of polymers
could be a reason for not detecting the polymer formation using mass spectrometry.
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Figure 29. Mass spectra using direct infusion of fractions collected from GPC column
containing (A) sodium acetate pH 5, (B) 4HBA in sodium acetate pH 5.0, and (C) 4HBA,
and laccase in sodium acetate pH 5.0.
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Figure 30. Mass spectra using direct infusion of fractions collected from GPC column
containing (A) water, (B) 4HBA in water, and (C) 4HBA, and laccase in water.
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Figure 31. Mass spectra using direct infusion of fractions collected from GPC column
containing (A) ammonium acetate pH 5.0, (B) 4HBA in ammonium acetate pH 5.0, and (C)
4HBA, and laccase in ammonium acetate pH 5.0.
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Conclusions
From the GPC experiment the monomer and the polymer were able to be observed using
UV absorbance at 250 nm and 280 nm. It could also be concluded that the 4HBA monomer and
polymer does not follow size exclusion behavior in that the monomer elutes before the polymer.
Further analysis needs to be performed in order to understand the polymer’s distribution.
Laccase Trametes versicolor, might require a size exclusion column which was used with
laccase, Trametes villosa.93

99

CHAPTER 5. MODIFICATION OF PES FLAT SHEETS AND MICRODIALYSIS
MEMBRANES WITH HEPARIN TO IMPROVE RELATIVE RECOVERY

Introduction
Microdialysis is a frequently used sampling technique to collect analytes from the
extracellular fluid space within an organism. Researchers are interested in the proteins found in
the extracellular fluid space but one of the challenges to analyzing proteins is their low
concentration and their low RR which makes them difficult to detect. One method that has been
previously used to increase the RR is to add a capture agent for the protein of interest into the
perfusion fluid. Heparin is an affinity agent that is known to bind a wide variety of proteins,
including growth factors such as aFGF, VEGF and TGF-β.44 Heparin is also known to bind to
IL-8, CCL2, MIP-1, RANTES and TNF-α with nM affinity.45-48 This chapter focuses on the
characterization of the heparin modification on PES flat sheets and hollow fibers using the
following reaction scheme (Figure 32), as well as the RR of three heparin binding proteins.

Laccase
4HBA

EDC/NHS
ED

EDC/NHS
Heparin

Figure 32. Reaction scheme for attachment of heparin onto PES membrane surface.
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Materials and Methods
Materials
Laccase form Trametes versicolor, sodium acetate, heparin sodium salt from porcine
intestinal mucosa, fluorescein isothiocyanate dextran 4,000, fluorescein isothiocyanate dextran
10,000, ethylenediamine dihydrochloride and methyl orange were purchased from Sigma Aldrich
(St. Louis, MO); 4-hydroxybenzoic acid was purchased from TCI (Portland, OR). 3-chloro-4hydroxybenzoic acid and 2-5-dihydroxybenzoic acid was purchased from Alfa Aesar (Haverhill,
MA). Sulfo-NHS premium grade, and HPLC grade methanol and water were purchased from
Fisher Scientific (Waltham, MA). Glacial acetic acid was purchased from VWR international
(Radnor, PA). NAP-25 Sephedex G-25 columns were purchased from GE healthcare (Chicago,
IL). Bovine Serum Albumin fraction V was purchased from Rockland (Pottstown, PA) and was
certified immunoglobulin and protease free. Lysozyme was purchased from MP biomedicals
(Solon, OH). The 100 kDa PES flat sheet membranes (UE50) were purchased from Sterlitech
(Kent, WA). Fluorescein isothiocyanate isomer 1 was purchased from Alfa Aesar (Haverhill,
MA). Dibasic sodium phosphate (ACS grade) was purchased from EMP (Howell, NJ). Sodium
chloride bioXtra grade, potassium chloride (99.0%), and monobasic potassium phosphate (ACS
grade) where purchased from Sigma Aldrich (St. Louis, MO). CMA 20 microdialysis probes
were purchased from Harvard Apparatus (Holliston, MA). CCL2 optiEIA ELISA kit was
purchased from BD bioscience (San Jose, CA). Recombinant rat KC/GRO, and mouse aFGF,
and VEGF Duo set ELISA kits were purchased from R&D systems (Minneapolis, MN).
Recombinant mouse FGF1 was purchased from Sino Biologicals (Beijing, China) and
recombinant mouse VEGF was purchased from Life Technologies (Carlsbad, CA). EDAC-HCl
was purchased from Amresco (Dallas, TX).
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Modification to PES Flat Sheets for XPS and ATR-FTIR Analysis
Initially, the heparin modification procedure was performed on PES flat sheets due to the
ease of analysis using ATR-FTIR and cost effectiveness compared to microdialysis probes.
Modification of the 100 kDa PES flat sheets were performed using the procedure described in
Chapter 4. Briefly, membranes were allowed to react in the 4HBA polymerization solution for 1,
2, 3 and 4 days and then were placed in a solution of 0.1 M sodium acetate pH 5.0 overnight to
wash the membranes. These membranes were then analyzed with ATR-FTIR. These
membranes were then modified with ethylenediamine (ED) in order to attach a primary amine to
the surface of the carboxyl-functionalized membranes. This was done by first adding 10 mg of
1-ethyl-3-(3-dimethylaminopropyl) carbodimide (EDC) to a 30 mL solution of 0.1 M MES
buffer at pH 5.5 with the flat sheet membranes. Then 28 mg of sulfo-NHS (Nhydroxysuccinimide) was added to this solution. This mixture was allowed to react for 30
minutes at room temperature. Next, the membranes were removed from this solution, placed in a
solution containing 60 mg of ED in 30 mL of PBS (137 mM NaCl, 10 mM phosphate, 2.7 mM
KCl) at pH 7.4 and allowed to react for 24 hours at room temperature. The membranes were
then placed in a solution of PBS pH 7.4 overnight at room temperature.
To heparin modify the ED modified membranes; the membranes were placed in a
solution containing 27 mg of EDC and 65 mg of sulfo-NHS in 30 mL 0.1 M MES buffer pH 5.5
for 30 minutes. Then, the membranes were placed in a solution containing 30 mg of heparin in
30 mL of PBS pH 7.4 for 24 hours. Later, the membranes were removed from the solution and
rinsed overnight in PBS pH 7.4. After each modification step the PES flat sheets were placed in
a desiccator and analyzed using ATR-FTIR.
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Protein Adsorption to Heparin Modified Membranes
Protein adsorption was measured to determine if the addition of heparin onto the
membrane surface would reduce protein adsorption of BSA and lysozyme. In order to test the
protein adsorption, BSA and lysozyme were FITC-labeled. FITC-BSA and FITC-lysozyme
were made using the procedure described in Chapter 2. PES flat sheet membranes were initially
reacted with 4HBA for 0, 1, 8, 12 and 24 hours using the procedure described in Chapter 2.
After the modification of the membranes with ED, the membranes reacted with heparin
described above, then the membranes were placed in a solution of FITC-BSA or FITC-lysozyme.
The concentration was compared with a solution that only contained FITC-BSA or FITClysozyme; based on the difference in fluorescence, the concentration adsorbed onto the surface
was calculated and converted to protein adsorbed per unit area using Equation 12 in Chapter 2.
Equilibrium Dialysis Experiments
Following ATR-FTIR and XPS data (which confirmed the attachment of heparin),
equilibrium dialysis experiments were performed. These experiments were performed using an
equilibrium dialysis chamber with a 1, 2, 3 and 4 day 4HBA modified membranes with heparin
attached. These experiments were performed by placing a 25 μL amount of buffer (PBS + 0.1%
(w/v) BSA) in one chamber, either the PET side or PES side of the membrane and then placing 4
ng/mL of CCL2 in the opposite chamber. The samples were then collected after 24 hours, and
then each side was incubated in a solution of 2 M NaCl in PBS at pH 7.4 for 30 seconds, 1
minute, 1 hour and 24 hours. The concentration was then increased to 112 ng/mL to increase the
likelihood of detecting CCL2 on both sides of the chamber.
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Nonspecific Adsorption of BSA to the Equilibrium Dialysis Chamber
To better understand the reasoning behind the sample loss observed in the CCL2
experiment above, the amount of BSA that nonspecifically adsorbed to the equilibrium dialysis
surface was calculated. In this experiment, a solution of 0.25 mg/mL of BSA was placed in the
equilibrium dialysis chamber with no membrane and allowed to incubate for 24 hours. The
solution was then removed and the concentration was determined using a standard bicinchoninic
acid (BCA) assay and compared to the initial solution.
FITC-10 and Methyl Orange Equilibrium Dialysis Experiment
To test the equilibrium dialysis chamber and the membranes with a simpler system,
FITC-10 equilibrium dialysis experiments were performed. This was done by placing a 100 kDa
PES flat sheet that had been soaked overnight in PBS pH 7.4 into the chamber. One side of the
chamber contained 25 μL of 1.2 mM FITC-10 and PBS was placed on the PES side of the
membrane. A 2 μL sample was collected from each side and from the stock solution at
approximate times of 1, 3, 7 and 22 hours. These samples were then analyzed by measuring the
absorbance at 492 nm.
Since 90 to 95% of the FITC-10 solution adsorbed onto the membrane, this experiment
was repeated with a 300 kDa PES flat sheet with methyl orange. Methyl orange has a molecular
weight of 327 Da. A 5 mM methyl orange solution was placed on the PET side of the membrane
and then PBS pH 7.4 was placed on the PES side of the membrane. Then, 2 μL samples were
collected from each side at 1, 2, 5 and 24 hours and absorbance values measured at 460 nm.
Attachment of Heparin to Microdialysis Membranes
After confirming the attachment of heparin to PES flat sheet membranes the method was
applied to the modification of microdialysis membranes. The modification of PES microdialysis
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membranes was performed by first attaching 4HBA polymers onto the surface using the method
described in chapter 2. Briefly this was performed by perfusing a solution containing 28.8 mM
of 4HBA and 0.5 U/mL of laccase from Trametes versicolor that was dissolved in 0.1 M sodium
acetate buffer pH 5.0 at a flow rate of 1 μL/min for 2 hours or 24 hours. Following modification,
the probe was flushed with 0.1 M sodium acetate buffer pH 5.0 overnight at a flow rate of 3
μL/min.
Then, these membranes were modified with ED in order to attach a primary amine to the
surface of the carboxyl-functionalized membranes. This is in order to attach heparin using
EDC/NHS chemistry. To attach ED, 2 mg of EDC was added to 200 μL of 0.1 M MES buffer at
pH 5.5. Then, 5.5 mg of sulfo-NHS was added to this solution. This mixture was then perfused
through the microdialysis probe for 45 minutes at 1 μL/min. Then a solution containing 10 mg
of ED in PBS at pH 7.4 was perfused through the probe at 1 μL/min for 24 hours. The probe
was then flushed with PBS pH 7.4 at 3 μL/min overnight.
To heparin modify the ED modified microdialysis membranes 4 mg of EDC and 12 mg
of sulfo-NHS were added to 200 μL of 0.1 M MES buffer pH 5.5. This mixture was perfused
through the microdialysis probe for 45 minutes at 1 μL/min. Then, a solution containing 10 mg
of heparin in PBS pH 7.4 was perfused through the probe at 1 μL/min for 24 hours. The probe
was then flushed with PBS pH 7.4 at 3 μL/min overnight. XPS was used to confirm the
attachment of 4HBA polymers and heparin.
FITC-Dextran and Lysozyme Relative Recovery Experiments
To test how this modification affected the membrane surface a FITC-4 RR experiment
was performed. CMA20 microdialysis probes were modified with 4HBA polymer for 24 hours
ED, and heparin. Then, between each step FITC-4 RR was measured. The FITC-4 RR
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experiment was performed by perfusing with PBS at pH 7.4 (perfusion fluid) at a flow rate of 1
μL/min through a microdialysis probe placed in a solution containing 500 μM FITC-4 in
perfusion fluid. Samples were collected every 20 minutes for a total of 60 minutes, and
absorbance values were measured in triplicate for each sample at 493 nm. Concentrations were
determined using a calibration curve generated that day. Also FITC-4, FITC-10, and FITC-20
RR was determined for 2 hour and 24 hour 4HBA-heparin modified microdialysis membranes.
Also, RR of lysozyme was performed using 500 μg/mL of lysozyme with a perfusion fluid of
PBS at pH 7.4 at a flow rate of 1 μL/min. Samples were collected every 30 minutes for a total of
2 hours and were analyzed using a standard BCA assay.
KC/GRO Relative Recovery Experiment
After confirming the attachment of heparin onto microdialysis membranes the relative
recovery of KC/GRO was obtained. For KC/GRO RR experiments, control and 24 hour heparin
modified microdialysis probes were compared. To determine the RR the probes were placed in a
solution containing 2,000 pg/mL of KC/GRO in PBS 0.1% BSA at pH 7.4. Microdialysis probes
were perfused at 1 μL/min with PBS 0.1% BSA at pH 7.4 and samples were collected every hour
for a total of 4 hours. The samples were then analyzed using a standard KC/GRO ELISA kit.
Heparin Binding Protein Relative Recovery Experiments
Next, RR of three heparin binding protein was determined. For these experiments, 2 hour
and 24 hour 4HBA modified and heparin modified microdialysis probes, were compared with
control (unmodified) microdialysis probes. To determine the RR of these analytes, the probes
were placed in a solution containing 6 ng/mL of CCL2, 800 ng/mL of aFGF, or 200 ng/ml of
VEGF in PBS 0.1% BSA at pH 7.4. Probes were perfused with PBS 0.1 % BSA at pH 7.4 at 1
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μL/min. Samples were collected every hour for a total of 4 hours and analyzed using a standard
CCL2, aFGF, or VEGF ELISAs.
Results and Discussion
ATR-FTIR Analysis of ED and Heparin Modified PES Flat Sheets
To confirm the attachment of heparin onto PES flat sheet membranes, XPS and ATRFTIR analyses were performed. The ATR-FTIR results show the presence of a carboxylic acid
functional group by the peak at approximately 3300 cm-1 in Figure 33(A), shown for comparison
purposes from Chapter 2. Upon modification with ED as shown in Figure 33(B), there is a
disappearance of the peak at approximately 3300 cm-1 indicating that the primary amine reacted
with the carboxylic acid functional group that was present in the 4HBA modified membranes.
Also, the weak peak at 3300 cm-1 could indicate remaining carboxylic acid or a secondary amine.
In Figure 34, the PET side shows water is not present in the membrane and that ED does not
react with the PET side of the membrane.
The next step was to attach heparin to the ED functionalized membranes. After
modification with heparin ATR-FTIR analysis was performed on the membranes. As seen in
Figure 35 there is an increase in the peak at approximately 3300 cm-1 indicative of the hydroxyl
functional groups on heparin. This peak is not present in the ED functionalized membranes
shown in Figure 33(B). Moreover, the PET side (Figure 36) shows the absence of water and that
the reaction is selective for the PES side.
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Figure 33. (A) IR spectra of the PES side of flat sheet membranes modified with 4HBA for
0 (PES), 1, 2, 3, and 4 days. (B) IR spectra of the PES side of flat sheet membrane for 0
(PES), 1, 2, 3, and 4 day modifications with 4HBA after attachment of ED.
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Figure 34. IR spectra of the PET side of flat sheet membrane for PES, 1 day modification,
2 day modification, 3 day modification, 4 day modification with 4HBA after attachment of
ED.
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Figure 35. IR spectra of the PES side of flat sheet membranes for PES, 1 day modification,
2 day modification, 3 day modification, 4 day modification with 4HBA after attachment of
heparin.
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Figure 36. IR spectra of the PES side of flat sheet membranes for PET, 1 day modification,
2 day modification, 3 day modification, 4 day modification with 4HBA after attachment of
heparin.
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Analysis of PES Flat Sheets Modified with Heparin using XPS
The next step was to analyze the heparin modified membranes using XPS. This was done
to further confirm the attachment of heparin on the membrane surface. The results from XPS
analysis, shown in Table 12, show the presence of S2p in the heparin modified membranes.
Since heparin is highly sulfonated, the presence of S2p indicates the presence of heparin. There
is also a decrease in the presence of the C-S functional groups for the heparin modified
membranes and a decrease in the C-S present in the 4HBA modified membranes. The C-S
functional group is found only in the sulfone group on PES so the decrease in C-S indicates the
addition of a substance onto the surface (4HBA, and heparin). There is also a significant
increase in the COOH functional groups for the 4HBA modified membranes, and for the heparin
modified membranes. Also, the binding energy of the COOH functional groups for the 4HBA
and heparin modified membranes are different. This indicates a different chemical environment
which would be expected because 4HBA and heparin have different structures. There was also
no significant change in the C-H/C-C content. In addition, there was also no significant
difference in the heparin modified membranes based on the length of 4HBA modification
between 1 and 4 day modification.
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Table 12. Three PES flat sheet membranes analyzed using XPS. Percentages are determined from the peak areas of the C1s,
O1s, and S2p high resolution XPS spectra. * indicates a significant difference from the sodium acetate control, 4HBA control,
and 3Cl4HBA control at the 95% confidence level using a single factor ANOVA with Bonferroni post hoc test. ND indicates
not detected (<0.1 atom%). For statistical analysis ND values were replaced with the detection limit (0.1 %).

Binding Energy
(eV)
Control
Laccase Control
4HBA Control
4HBA Modified
1 Day-4HBAHeparin
2 Day 4HBAHeparin
3 Day 4HBAHeparin
4 Day 4HBAHeparin

C-C/C-H

C-O-C

C-S

O-C

O-S

284.77
±0.027
55.32 ±
3.33%
47.00 ±
5.47%
57.25 ±
0.78%
58.26 ±
4.34%
61.27±
6.27%
56.50 ±
0.12%
57.55 ±
0.97%
58.64 ±
1.00%

286.25
±0.080
13.89 ±
0.95%
23.28
±0.89%*
13.05 ±
2.97%
11.68 ±
1.41%
8.42 ±
1.98%
7.82 ±
1.16%
7.52 ±
0.91%
7.14 ±
1.25%

288.82
±0.097
7.79 ±
0.95%
8.51 ±
0.57%
7.20 ±
0.79%
3.50 ±
1.10%*

531.73
±0.15
12.54 ±
0.96%
14.06 ±
4.38%
13.09 ±
1.43%
14.40 ±
6.96%
16.97 ±
1.35%
19.51 ±
1.07%
18.53 ±
0.41%
17.38 ±
1.01%

533.43
±0.14
10.46 ±
1.07%
7.15 ±
1.32%
9.41 ±
1.40%
3.59 ±
1.36%*
2.32 ±
1.80%*
2.07 ±
0.77%*
3.18 ±
0.40%*
2.89 ±
0.22%*

ND*
ND*
ND*
ND*

COOH4HBA
287.45
±0.18

COOHheparin
287.85
±0.14

ND

S2p

S2p

167.67
±0.059

168.87
±0.068

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

ND

8.57 ±
0.83%*

ND

ND

ND

5.29 ±
2.23%*
7.33 ±
0.16%*
5.99 ±
1.27%*
6.63 ±
0.90%*

1.50 ±
0.11%*
1.20 ±
0.18%*
1.46 ±
0.06%*
1.58 ±
0.04%*

0.92 ±
0.27%*
0.77 ±
0.02%*
0.87 ±
0.07%*
0.97 ±
0.15%*

ND
ND
ND
ND
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FITC-BSA and Lysozyme Adsorption
To analyze protein adsorption onto the heparin modified PES flat sheets, BSA and
lysozyme adsorption were determined. This experiment was performed by using PES flat sheets
that were modified with 4HBA for the specified time shown (Figure 37 and 38), and then reacted
with ED and heparin. The results for FITC-lysozyme show an increase in protein adsorbed as
the 4HBA modification time increased (Figure 37). This could be due to an increase in the
amount of heparin on the surface and/or the increase in unreacted 4HBA on the surface. Since
the protein adsorption increased with heparin modification that could indicate a charge-charge
interaction between the negatively charge membrane surface with an overall positively charged
for lysozyme. For FITC-BSA (Figure 38), there was no significant difference between the
control membranes and the membranes modified with heparin. This shows that BSA adsorption
does not decrease upon addition of heparin to the membrane surface.
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Figure 37. Lysozyme adsorption onto PES membranes modified with 4-hydroxybenzoic
acid (4HBA) polymers for 1, 8, 12, and 24 hours then heparin modified compared to
control PES membranes. N=3 * indicates a significant difference at the 95% confidence
level compared the control using a single factor ANOVA with Bonferroni post hoc test.
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Figure 38. BSA adsorption onto PES membranes modified with 4-hydroxybenzoic acid
(4HBA) polymers for 1, 8, 12, and 24 hours then heparin modified compared to control
PES membranes. N=3, * indicates a significant difference at the 95% confidence level
compared the control using a single factor ANOVA with Bonferroni post hoc test.
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Equilibrium Dialysis Experiments
Equilibrium dialysis experiments were performed to provide a way to test the transport
across the PES flat sheet membranes modified with heparin. An initial experiment was
performed to test if by placing the affinity agent on the same side or opposite side of the target
(CCL2), it would increase transport. The results from this experiment (Table 13) show that
placing the affinity agent and the target on the same side showed a non-detectable concentration
for each side of the membrane. This could be due to the binding of CCL2 to the heparin side
making the levels not detectable in solution. Also, by placing the CCL2 on the PET side and the
heparin modification being on the PES side, CCL2 was observed on the PET side. However,
CCL2 was only detected on the heparin modification side for the 2 day 4HBA modified, heparin
modified membrane. This could be due to the binding on the heparin and CCL2. The samples
collected after incubation with 2 M NaCl showed non-detectable concentrations of CCL2
indicating that the bound CCL2 was not removed by the addition of NaCl.
The concentration of CCL2 was then increased to 112 ng/mL (Table 14) observable
concentrations of CCL2, however when this experiment was repeated, concentrations of CCL2
were not detectable. This could be due to the binding of CCL2 to the membrane surface and
blocking pores since a significant portion of the 112 ng/mL CCL2 concentration was lost to the
equilibrium dialysis chamber and the membrane.
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Table 13. Equilibrium dialysis experiment using 4,000 pg/mL of CCL2 placed on either the
same side or opposite side of the heparin modification inside the chamber for 24 hours.
Samples were then collected from each side and analyzed using a CCL2 ELISA. ND= not
detected (<31 pg/mL).
Opposite Side

Same Side

Heparin
PET with
Heparin
PET (pg/mL)
4HBA Reaction PES
CCL2
4HBA Reaction PES
Time (Days)
(pg/mL)
(pg/mL)
Time (Days)
(pg/mL)
1
ND
480
1
ND
ND
2
270
1110
2
ND
ND
3
ND
450
3
ND
ND
4
ND
450
4
ND
ND
PES
ND
ND
PES
ND
ND

Table 14. Equilibrium dialysis experiment using 112 ng/mL of CCL2 placed on the
opposite side of the heparin modification inside the chamber for 24 hours. Samples were
then collected from each side and analyzed using a CCL2 ELISA.
4HBA Reaction Time (Days)
1
2
3
4

Heparin side (PES) (ng/mL)
PET side (ng/mL)
10.4
13.8
1.8
2.7

0.3
0.5
0.3
0.1

Nonspecific Adsorption of BSA to the Equilibrium Dialysis Chamber
BSA adsorption to the equilibrium dialysis chamber was calculated to determine to what
extent protein is adsorbing onto the equilibrium dialysis chamber. The determined amount of
loss of BSA to the equilibrium dialysis chamber was 0.54 μg/cm2 this was 23% of the original
BSA added to the container. Although the experiments performed with CCL2 did have a
concentration of 0.1% BSA as a blocking agent, this could explain some of the loss of the
analyte (CCL2).

118

FITC-10 and Methyl Orange Equilibrium Dialysis Experiments
FITC-10 and methyl orange equilibrium dialysis experiments were performed in order to
provide a simpler system to better understand the sample loss that is occurring in these
equilibrium dialysis experiments. The results for this experiment (Figure 39) show that
compared to the starting concentration, the PET side decreases in concentration. However, the
PES side did not increase as rapidly to match the decrease in concentration from the PET side.
This indicates that the FITC-10 is either adsorbed onto the material and/or trapped inside the
pores which can be visibly seen by a yellow color when the membrane is removed from the
module.
Since FITC-10 was adsorbing to the membrane surface with the 100 kDa PES flat sheets,
an experiment was performed with methyl orange with 300 kDa PES flat sheets. The data from
this experiment (Figure 40) show a decrease in the concentration of the PET side compared to
the starting concentration. The PES side does not show a corresponding increase in methyl
orange concentration, indicating that the methyl orange is trapped inside the membrane.
Although equilibrium is reached between hours 2 and 5 indicated by the absorbance values being
almost identical, there is still significant loss of the methyl orange to the membrane surface
which is observed by the orange color of the membrane.
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Figure 39. Equilibrium dialysis data for FITC-10 on 100 kDa PES flat sheet membranes.
The side of the chamber that exposed the PES side of the membrane contained the initial
FITC-10 solution labeled PES above and the side of the chamber that exposed the PET side
of the membrane labeled PET above. Both sides of the chamber were analyzed.
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Figure 40. Equilibrium dialysis data for methyl orange for 300 kDa PES flat sheet
membranes. The side of the chamber that exposed the PES side of the membrane
contained the initial FITC-10 solution labeled PES above and the side of the chamber that
exposed the PET side of the membrane labeled PET above. Both sides of the chamber were
analyzed.
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Conclusions from Equilibrium Dialysis Experiments
After confirming the attachment of heparin on the PES flat sheets but determining that
transport across these flat sheets was hindered by the analyte adsorbing onto the membrane
surface and/or pores, microdialysis experiments were performed. The reason for making this
decision was based on previous research which showed that analytes could be collected in the
dialysate using microdialysis. The overall goal of using the flat sheet membranes was to
understand the chemistry to attach heparin onto the surface. This was successful in confirming
the attachment of heparin onto the PES flat sheet membranes. The information provided through
the equilibrium dialysis experiments could provide insight into mass transport enhancement
however these membranes are typically used in pressurized systems and are rated for such
systems, so it was difficult to see transport using an equilibrium dialysis chamber. Applying a
pressurized system for cytokine collection would be difficult due to the increase in sample size
that would be needed.
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Effect of Heparin Modification of Microdialysis Membranes on Relative Recovery of
Heparin Binding Proteins
After confirming the attachment of heparin to PES flat sheets, the method was applied to
the membrane of microdialysis probes. To confirm the attachment of heparin to microdialysis
membranes XPS analysis was performed and then the RR experiments were performed. Initially
FITC-4, FITC-10, and FITC-20 were used to determine if heparin modification reduced RR
significantly due to pore blockage caused by the modification. Next, RR of three heparin
binding proteins (CCL2, VEGF, and aFGF) was determined as well as KC/GRO. The reason for
choosing these heparin binding proteins was that CCL2 has a slow off rate compared to VEGF,
and aFGF. This will test if RR enhancement is affected by the off rate.
Modification of Microdialysis Membranes with Heparin
XPS analysis was performed on microdialysis membranes in order to confirm the
attachment onto the membrane surface. Results from XPS analysis, Table 15, show that the
carboxylic acid functional group is found in the heparin modified membranes and not present in
the control membranes. There is also a decrease in the C-S functional group to below detectable
levels upon modification with heparin. Also, there is a significant increase in the percentage of
sulfur 2p found in heparin modified membranes. The carboxylic acid functional group is found
in both heparin and 4HBA modifications, but the increase in the amount S2p present can only
come from the addition of heparin to the membrane surface which confirms the attachment of
heparin to the microdialysis membrane.
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Table 15. XPS data from control 4HBA and heparin modified microdialysis membranes.
Percentages are determined from the peak areas of the C1s, O1s, and S2p high resolution
XPS spectra. * indicates a significant difference from the control at the 95% confidence
level using a single factor ANOVA with Bonferroni post hoc test. # indicates significant
difference from the 4HBA modified MD membrane at the 95% confidence level. ND
indicates not detected (<0.1%).

Binding Energy
(eV)
Control
4HBA Modified
Heparin Modified

C-C/C-H
284.64 ±
0.15
54.65 ±
10.40%
49.83 ±
11.88%
56.60 ±
4.66%

C-O
285.75 ±
0.38
22.54 ±
6.76%
17.68 ±
6.50%
22.35 ±
17.93%

COOH
287.72 ±
0.35
ND
9.73 ±
5.94%*
3.23 ±
2.86%*

S2p
167.89 ±
0.17
3.12 ±
1.14%#
0.85 ±
0.18%*
2.31 ±
0.49%#

O-C
531.82 ±
0.32
15.14 ±
5.07%
14.81 ±
4.36%
22.30 ±
11.52%

O-S
533.54 ±
0.24
3.15 ±
0.64%
ND
ND

FITC-Dextran and Lysozyme Relative Recovery
After confirming the attachment of heparin to microdialysis probes RR experiments were
performed. First FITC-4 RR was analyzed to determine if the modification with heparin blocked
pores inhibiting the RR. FITC-4 relative recovery was determined for microdialysis membranes
initially, and after 4HBA, ED, and heparin modifications. This was determined to see if
recovery of FITC-4 would be affected by the modification. The results from this experiment
(Figure 41) show a significant decrease in the RR of FITC-4 after modification with 4HBA
polymerization solution for 24 hours. The RR for FITC-4 does not change after modification
with ED and heparin, indicating that after modification for 24 hours with 4HBA, that the
addition of ED and heparin does not further decrease the RR of FITC-4. After testing the RR for
FITC-4 with a 24 hour 4HBA modification time, the RR was analyzed with 2 hour and 24 hour
4HBA-heparin modified probes and compared to the control for FITC-4, FITC-10, and FITC-20
as well as lysozyme. For FITC-4 (Figure 42), FITC-10 (Figure 43), and FITC-20 (Figure 44),
the RR was significantly lower after heparin modification compared to the control. For
124

FITC-4 and FITC-20 the decrease in RR for heparin modified membranes when compared to the
4HBA modification was not significantly different for the 24 hour modification time but was
significantly lower for the 2 hour modification time. For FITC-10, RR for the 2 hour 4HBA
modification time before and after heparin modification was not significantly different but FITC10 RR was significantly higher for the 24 hour modification time after heparin modification
compared to before heparin modification.
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Figure 41. FITC-4 relative recovery for the same control, 24 hour 4HBA, ethylenediamine,
and heparin modified microdialysis probes. N=3 *indicates a significant difference at the
95% confidence level compared the control using a two factor ANOVA with Bonferroni
post hoc test.
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Figure 42. FITC-4 relative recovery for control, 2, and 24 hour 4HBA-heparin modified
microdialysis probes. N=3, * indicate significant difference at the 95% confidence level
using a two factor ANOVA with Bonferroni post hoc test.
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Figure 43. FITC-10 relative recovery for control, 2, and 24 hour 4HBA-heparin modified
microdialysis probes. N=3, * indicate significant difference at the 95% confidence level
using a two factor ANOVA with Bonferroni post hoc test.
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Figure 44. FITC-20 relative recovery for control, 2, and 24 hour 4HBA-heparin modified
microdialysis probes. N=3, * indicate significant difference at the 95% confidence level
using a two factor ANOVA with Bonferroni post hoc test.
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Figure 45. Lysozyme relative recovery for control, 2 hour, and 24 hour 4HBA-heparin
modified microdialysis probes. Probes were placed in a solution containing 500 μg/mL of
lysozyme. N=3
Lysozyme RR, shown in Figure 45, shows no significant difference between the control
and after heparin modification regardless of 4HBA modification time. What is interesting about
this is that for the 24 hour 4HBA modification, the RR was below the detection limit of the assay
(25 μg/mL); upon modification with heparin the RR increased to a value that was not
significantly different than the control RR.
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Relative Recovery of KC/GRO for Control, 2 Hour and 24 Hour 4HBA-Heparin Modified
Microdialysis Membranes
Next RR for KC/GRO was tested with control, 2 and 24 hour heparin modified
microdialysis membranes. KC/GRO was also analyzed because the human analog of rat
KC/GRO is IL-8 which is a known heparin binding protein.139 The reason for testing this analyte
was to see if RR enhancement could be observed which could be an indication of KC/GRO
binding to heparin. The results for this experiment (Figure 46) show no enhancement in RR for
the 24 hour 4HBA-heparin modified membranes compared to the control membranes. For the 2
hour 4HBA-heparin modified membranes relative recovery approximately doubled. This could
indicate that KC/GRO is binding to the heparin modification on the membrane surface. The
increase in RR could also be due to a charge-charge interaction between the negatively charge
surface and KC/GRO because the results are similar to what was observed for the 2 hour 4HBA
modified microdialysis membranes. This could indicate that the heparin modification is also
reducing nonspecific adsorption of KC/GRO leading to an increase in RR.
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Figure 46. Box and whiskers plot of KC/GRO relative recovery of control 2 hour and 24
hour 4HBA-heparin modified microdialysis probes. N=3 * Indicates significantly different
than the control at the 95% confidence level as determined by a 2 factor ANOVA with
Bonferroni post hoc test.
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Relative Recovery of CCL2, aFGF, and VEGF for Control, 2 Hour, and 24 Hour 4HBAHeparin Modified Microdialysis Membranes
RR was calculated for CCL2, aFGF and VEGF. These three analytes are known heparin
binding proteins and also have both fast (VEGF, aFGF) and slow off rates (CCL2). These are
known heparin binding proteins, so RR was determined to test if by adding heparin as an affinity
agent to the membrane surface would increase RR. From this information more insight will be
given into the factors that affect the RR enhancement by affinity agents like heparin.
For the 24 hour 4HBA-heparin modified microdialysis probes, there is a significant
increase in RR observed for hours 2 to 4 (Figure 47). The increase at hour 2 is approximately
20% and for hours 3-4 is close to 100%. For the 2 hour 4HBA-heparin modified microdialysis
probes, there is no significant difference between the control and the 2 hour 4HBA-heparin
modified microdialysis probes (Figure 48). For the 24 hour 4HBA-heparin modified
membranes, the RR increase after hour 1 may be that the rate of binding of CCL2 to heparin is
faster than the rate of release. After hour 1 an equilibrium phase where the rate of binding and
releasing is equal; this allows for the increase in RR due to the blocking of irreversible binding
sites by the addition of heparin onto the membrane surface. For the 2 hour 4HBA-heparin
modified microdialysis membranes there may be insufficient heparin on the surface to observe a
significant increase in RR.
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Figure 47. Box and whiskers plot of CCL2 RR of control and 24 hour 4HBA-heparin
modified MD probes. N=6 for control, and N=3 for 24 hour 4HBA-heparin modified MD
probes. * indicates significance at the 95% confidence level.
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Figure 48. Box and whiskers plot of CCL2 RR of control and 2 hour 4HBA-heparin
modified MD probes. N=6 for control MD probes and N=3 for 2 hour 4HBA-heparin
modified microdialysis probes.
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Figure 49. Box and whiskers plot of aFGF relative recovery of control, 2 hour and 24 hour
4HBA-heparin modified MD probes. N=3. * indicates significance at the 95% confidence
level.
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The next analyte that was tested was aFGF which has a fast off rate compared to CCL2.
The results from the aFGF in vitro microdialysis experiment in Figure 49 show a significant
increase in RR after hour 2 for the 2 hour 4HBA-heparin modified microdialysis probes. The
RR for 24 hour 4HBA-heparin modified microdialysis probes did not change significantly.
CCL2 is 13.1 kDa (pI 9.25) and is slightly smaller than aFGF at 15.5 kDa (pI 5.6). Since aFGF
is approximately 2 kDa larger in mass compared to CCL2, the 24 hour 4HBA modification time
may exclude more of the aFGF compared to the CCL2. This may be the reason the RR for aFGF
did not increase for the 24 hour 4HBA-heparin modified microdialysis membranes. For the 2
hour 4HBA-heparin modifications since aFGF has a slightly higher on-rate and a faster off rate,
more heparin may not need to be bound to the surface in order to see RR enhancement.
Next, VEGF relative recovery was determined for control, 2 hour and 24 hour 4HBAheparin modified microdialysis membranes. VEGF RR results for 2 hour 4HBA-heparin
modified and 24 hour 4HBA-heparin modified membranes are shown in Figure 50. For the 24
hour 4HBA-heparin modification there was a significant difference in RR for VEGF compared
to the control. The increase in RR observed is slight compared to the control. VEGF is larger at
21 kDa than CCL2 and aFGF at 13.1 and 15.5 kDa. Since it is known that the modification with
4HBA can decrease the pore size, especially at the 24 hour reaction time, the transport of VEGF
RR may decrease more due to the pore size decrease than can be compensated for by the affinity
interaction on the membrane surface. This could also explain why there is no significant
difference in the RR for the 2 hour 4HBA-heparin modification because there is possibly less
heparin on the surface.
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Figure 50. Box and whiskers plot of VEGF relative recovery of control, 2 and 24 hour
4HBA modified microdialysis probes. N=3 * Indicates significantly different than the
control at the 95% confidence level as determined by a 2 factor ANOVA with Bonferroni
post hoc test.
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With the attachment of heparin onto the membrane surface, RR of CCL2, aFGF, and
VEGF were analyzed. CCL2 RR increased twofold at hours 3 and 4 for the 24 hour 4HBAheparin modification. For aFGF RR for the 2 hour 4HBA-heparin modified MD probes
increased twofold for hours 3 and 4. CCL2 is smaller at 13.1 kDa than aFGF at 15.5 kDa. Since
the 24 hour modification is shown to inhibit transport this could explain why the increase in RR
for aFGF is not observed for the 24 hour modification time. This may also explain why the
increase in RR for VEGF is also small for the 24 hour modification time because VEGF is 21
kDa.
Conclusions
This chapter shows successful attachment of heparin on to PES flat sheets and
microdialysis membranes shown by XPS and ATR-FTIR analysis. Protein adsorption
experiments show no significant change in adsorption for BSA and an increase in adsorption of
lysozyme for 12 and 24 hour modification times. Equilibrium dialysis experiments were
attempted with heparin modified flat sheets but there was a high amount of analyte binding to the
membrane surface and pores. FITC-4, FITC-10, and FITC-20, RR was calculated and showed
that upon addition of ED and heparin that the recovery did not decrease compared to the initial
decrease from addition of 4HBA. Relative recovery of CCL2 increased 2 fold at hours 3 and 4
and for VEGF at all collection times for the 24 hour 4HBA-heparin modified membranes. These
RR enhancements were less than what was observed with using heparin-immobilized
microspheres for CCL2 and VEGF of 4 fold and 2 fold increases, but this could be due to the
reduction in pore size due to the modification.53 This could be improved upon by testing
different 4HBA, and heparin modification times. Also aFGF showed a 2 fold increase in RR for
hours 3 and 4 for 2 hour 4HBA-heparin modified membranes. This increase in RR was not
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observed under the same flow rate conditions of 1 μL/min with heparin modified microspheres
so by adding heparin to the membrane surface the RR was enhanced twofold which is an
improvement on the previously used method.53 By doubling the RR the concentration required
to detect these analytes is reduced by half. For example for CCL2 the detection limit for the
ELISA assay is 31 pg/mL so with a RR of 3.84% the minimum amount of CCL2 needed outside
the probe to be detected by this assay would be 806 pg/mL. With the 24 hour 4HBA-heparin
modification with an average RR of 6.56% at hours 3 and 4 the required amount of CCL2 needed
outside the probe would be 472 pg/mL. By increasing the RR the analyte is able to be detected
at a lower concentration. If the analyte is indicative of the onset of a specific condition or
disease being able to detect this analyte at a lower concentration could ultimately lead to
detecting the condition or disease marker sooner.
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CHAPTER 6. CONCLUSIONS AND FUTURE PROSPECTS

Microdialysis is a technique which has the ability to sample the extracellular fluid space
surrounding the membrane but one of the challenges to this technique is the ability to sample
proteins which have low relative recovery and are at low concentrations (ng/mL-pg/mL range).
This introduces a problem in detecting these proteins. An approach to solving this problem is to
increase the relative recovery of these proteins across the microdialysis membrane. By
increasing the relative recovery the amount of analyte external to the probe needed to detect this
analyte is reduced. For example is the relative recovery is doubled then the external
concentration needed for detection by the assay is reduced by half.
Introduction of perfusion fluid additives, such as BSA, antibodies, and heparin, have been
previously shown to increase relative recovery.7

These perfusion fluid additives look at two

different approaches to increasing relative recovery: reducing nonspecific adsorption (BSA), and
introducing an affinity interaction (heparin, antibodies). In this dissertation the membrane
surface was modified in order to study the enhancement of relative recovery using these two
different methods. To study the enhancement of relative recovery by reducing nonspecific
adsorption, 4-hydroxybenzoic acid polymers were covalently added to the membrane surface
using a laccase catalyzed reaction. To study the effect of relative recovery by attaching an
affinity agent, heparin was attached to the membrane surface.
Conclusions
To study how the addition of 4-hydroxybenzoic acid polymers altered relative recovery in
microdialysis, a method was devised to modify the microdialysis membrane surface using the
enzyme laccase. Laccase catalyzes the one-electron oxidation of four reducing-substrate
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molecules followed by the four-electron reduction of molecular oxygen to water.91 The overall
outcome of the catalytic cycle is the reduction of one molecule of oxygen to two molecules of
water and the concomitant oxidation of 4 substrate molecules to produce 4 radicals.91 These
4HBA radicals can then react with the PES surface as well as with other 4HBA molecules. The
reaction between 4-hydroxybenzoic acid and laccase was used to generate 4HBA polymers onto
the microdialysis membrane surface.
Confirmation of attachment of 4-hydroxybenzoic acid polymers onto PES flat sheets was
shown by the presence of hydroxyl peak from a conjugated carboxylic acid at approximately
3300 cm-1 on the IR spectrum, and the presence of carboxylic acid peak at 287.85 eV, a decrease
in C-S at 288.81 eV, and a decrease in O-S at 533.35 eV from C1s and O1s high resolution XPS
spectra. After confirming the attachment of 4-hydroxybenzoic acid polymers onto PES flat
sheets, BSA and lysozyme adsorption was analyzed and showed an initial increase in BSA
adsorption followed by a decrease in BSA adsorption with increasing modification time. This
shows that in order to see reduction in nonspecific adsorption the amount of polymer on the
surface in terms of both graft density and chain length must be reached in order to exclude BSA
adsorption onto the surface. Lysozyme protein adsorption increased upon modification with 4hydroxybenzoic acid possibly due to both charge-charge interactions with the carboxylic acid
functional groups and insufficient graft density to exclude lysozyme from binding to the surface.
After confirming the attachment of 4-hydroxybenzoic acid polymers onto PES flat sheet
membranes the reaction was performed on PES microdialysis probes and the attachment was
confirmed using XPS by the introduction of a carboxylic acid peak at 387.90 eV and the
reduction of the O-S peak at 532.99 eV to a non-detectable level. Two different modification
times were chosen, 2 and 24 hours. FITC-4, FITC-10, and FITC-20 relative recovery was
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initially tested to determine if the modification times selected inhibited transport across the
membrane; it was confirmed that the 24 hour modification time reduced relative recovery by 6070% and the 2 hour modification reduced relative recovery by 20-40%. To further confirm this
reduction in relative recovery upon modification with 4-hydroxybenzoic acid, lysozyme relative
recovery was not detected for the 24 hour modification, and the 2 hour modification was not
significantly different than the control (no modification). Since the adsorption of BSA and
lysozyme onto the PES flat sheets indicated that the adsorption was influenced by charge-charge
interactions between the adsorbing molecule and the surface, relative recovery was analyzed for
both proteins with pI greater and less than pH 7.4. These analytes were CCL2 (pI= 9.3),
KC/GRO (pI= 9.1), and VEGF (pI= 8.5), which have isoelectric points greater than pH 7.4 and
TNF-α (pI= 5.0), and aFGF (pI= 5.7), which have isoelectric points less than pH 7.4. The
relative recovery results from these analytes showed a 2 to 3 fold increase in relative recovery for
analytes that had an isoelectric point greater than pH 7.4 (CCL2, KC/GRO, VEGF) but no
significant increase in relative recovery for analytes with isoelectric points less than pH 7.4
(TNF-α, aFGF) for the 2 hour 4-hydroxybenzoic acid modified microdialysis probes.
After analyzing the effect of the 4-hydroxybenzoic acid modification on relative
recovery, this modification was used to further modify the membrane surface with heparin. This
was performed by a two-step process, attaching ethylenediamine to the carboxylic acid modified
membrane surface, and then attaching heparin to the amine modified membrane surface, both
using EDC/NHS chemistry. Attachment of ethylenediamine and heparin was confirmed by the
disappearance of the peak at 3300 cm-1, indicating that the surface did not contain the carboxylic
acid functional group at a significant quantity to be detected using ATR-FTIR; heparin
modification was confirmed by the reappearance of the peak at 3300 cm-1, indicating the
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presence of the carboxylic acid functional group. XPS results for the heparin modified flat
sheets showed peaks at 287.85 eV indicative of the carboxylic acid functional group and 167.67
eV, and 168.87 eV for S2p. There was also a decrease in C-S at 288.82 eV. BSA and lysozyme
protein adsorption to the PES flat sheet membrane showed no change in BSA adsorption, but an
increase in protein adsorption for the 12 and 24 hour modification times for lysozyme. This
increase in protein adsorption could indicate a charge-charge interaction between the highly
negatively charged heparin and the overall positively charge lysozyme.
After confirming the attachment of heparin onto PES flat sheets the method was applied
to PES hollow fiber microdialysis probes. XPS results show the presence of a carboxylic acid
peak at 287.72 eV ± 0.35 at 3.23% ± 2.86 for the heparin modified microdialysis membranes,
which is not detected for the control membranes. Also the O-S peak at 533.54 eV ± 0.24 for the
heparin modified membranes was not detectable compared the control at 3.15% ± 0.64. The S2p
peak is also greater than the S2p peak in the 4HBA modified microdialysis membrane.
After confirming the attachment of heparin to PES microdialysis membranes FITC-4,
FITC-10, and FITC-20 relative recovery was determined and showed no further decrease in
relative recovery compared to the decrease in relative recovery after modification with 4HBA.
Relative recovery for heparin binding proteins, CCL2, aFGF, and VEGF, was determined.
CCL2 showed a twofold increase in relative recovery for hours 3 and 4 for the 24 hour 4HBAheparin modifications time. This RR enhancement was less than the observed fourfold RR
enhancement with heparin immobilized microspheres but by doubling the RR with the 24 hour
4HBA-heparin modified surface this is still considered to be an improvement compared to using
an unmodified microdialysis membrane.53 The increase in RR CCL2 for the 24 hour 4HBAheparin modification could be due to the increase in heparin on the membrane surface with
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increased 4HBA modification time but the size of CCL2 is not significantly blocked by the
increase in modification. This may also explain why the RR enhancement was less than what
was observed with the heparin-immobilized microspheres because the pore size of the membrane
is, as was observed with the FITC-labeled dextrans, being reduced.
For aFGF the RR increased twofold for the 2 hour 4HBA-heparin modification. This was
not observed under the flow rate conditions (1μL/min) with perfusing heparin immobilized
microspheres so adding heparin to the membrane surface provided more significant enhancement
to RR compared to using heparin immobilized microspheres under the same flow rate
conditions.53 For the aFGF molecular weight is greater than CCL2 so aFGF may be blocked by
the 24 hour 4HBA-heparin modification which could explain why the RR did not increase with
the 24 hour 4HBA-heparin modification.
VEGF relative recovery was significantly different than the control for the 24 hour
4HBA-heparin modification time. VEGF (21 kDa) relative recovery for 24 hour 4HBA-heparin
modified membranes was significantly different than the control but the increase in relative
recovery was slight this could be due to pore blockage caused by the 24 hour 4HBA-heparin
modification leading reduced transport across the membrane. This could explain why with
heparin-immobilized microsphere the RR enhancement was 3.5-fold but with a heparin modified
surface the RR enhancement was approximately 25%.53 This could also be the case for CCL2
but since CCL2 is smaller at 13.1 kDa, CCL2’s diffusion through the modified membrane
surface is not as hindered compared to VEGF.
KC/GRO was also analyzed since it is the rat analog of IL-8, a known heparin binding
protein, and relative recovery increased with the 2 hour 4HBA-heparin modified microdialysis
membranes. A similar increase in relative recovery was observed for KC/GRO with the 2 hour
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4HBA modified microdialysis membranes. This increase could be due to the electrostatic
interaction between a negatively charged surface and KC/GRO (pI=9.1) with an overall positive
charge. This portion of the dissertation showed successful attachment of heparin onto the
microdialysis membrane surface.
Future Prospects
In this dissertation the 4HBA modification showed a trend towards increasing RR of
proteins with a pI greater than the pH of the buffer (pH 7.4), but not for proteins with a pI less
than the pH of the buffer. This could indicate an electrostatic attraction between proteins and the
negatively charged surface. An interesting future project could be to test if the opposite trend
could occur with the ethylenediamine modification performed before attachment of heparin. The
pKa of the removal of a proton from the first amine is 7.564 and the second is 10.71, so at pH 7.4
the surface would have an overall positive charge. This could be tested with the set of analytes
used in this project to see if altering the charged nature of the PES membrane surface could
increase RR of analytes with a pI less than 7.4. This trend could also be further studied for both
the carboxylic acid and ethylenediamine functionalization using carboxylic acid functionalized
SPR sensors. This could be used to investigate the kinetic parameters (kon, koff and KD) between
the protein and the surface.
A major area in membrane research is the modification of the membrane surface, and one
of the purposes of this project was to develop a method to attach molecules containing carboxyl
or amine functional groups onto the microdialysis membrane surface. With the attachment of
4HBA polymers onto the membrane surface, attachment of other amine or carboxyl containing
molecules can be attached to the membrane surface using EDC/NHS chemistry. This method
can be beneficial in a wide variety of ways. In this dissertation heparin was attached to the
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surface as a proof of principle experiment to modify the surface as well as to test the effect this
modification could have on relative recovery of heparin binding proteins. Another one of the
future prospects of the project could be to attach different analytes to the membrane surface.
This could be tailored to a wide variety of applications that use functionalized membrane
surfaces, such as biomaterials, catalysts in fuel cell systems, and membrane separations.
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